Summer Infant
Annual Report 2014

Plain-text annual report

SUMMER INFANT, INC. FORM 10-K (Annual Report) Filed 03/04/15 for the Period Ending 01/03/15 Address Telephone CIK Symbol SIC Code Industry 1275 PARK EAST DRIVE WOONSOCKET, RI 02895 401-334-9966 0001314772 SUMR 3990 - Miscellaneous Manufacturing Industries Personal & Household Prods. Sector Consumer/Non-Cyclical Fiscal Year 01/03 http://www.edgar-online.com © Copyright 2015, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use.  Use these links to rapidly review the document TABLE OF CONTENTS Index to Financial Statements Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Commission File No. 001-33346 SUMMER INFANT, INC. (Exact name of registrant as specified in its charter) (401) 671-6550 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Delaware (State or other jurisdiction of incorporation) 20-1994619 (I.R.S. Employer Identification No.) 1275 Park East Drive, Woonsocket, Rhode Island (Address of principal executive offices) 02895 (Zip Code) Title of each class Name of exchange on which registered (Mark One) (cid:1) ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 3, 2015 Or (cid:3) TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to  Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes (cid:3) No (cid:1) Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes (cid:3) No (cid:1) Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes (cid:1) No (cid:3) Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes (cid:1) No (cid:3) Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. (cid:3) Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "accelerated filer," large accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes (cid:3) No (cid:1) The aggregate market value of the voting and non-voting common equity held by non-affiliates, based on the closing price of the registrant's Common Stock as reported on the Nasdaq Capital Market on June 30, 2014, was $33.1 million. For purposes of this computation, all officers, directors, and 10% beneficial owners of the registrant are deemed to be affiliates. Such determination should not be deemed to be an admission that such officers, directors, or 10% beneficial owners are, in fact, affiliates of the registrant. The number of shares issued and outstanding of the registrant's common stock as of February 17, 2015 was 18,440,934 (excluding unvested restricted shares that have been issued to employees). DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant's Proxy Statement for its 2015 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K. Common Stock, Par Value $0.0001 Nasdaq Capital Market Large accelerated filer (cid:3) Accelerated filer (cid:3) Non-accelerated filer (cid:3) (Do not check if a smaller reporting company) Smaller reporting company (cid:1) Table of Contents INDEX TO FORM 10-K FOR THE FISCAL YEAR ENDED JANUARY 3, 2015 PAGE PART I ITEM 1. Business 1 ITEM 1A. Risk Factors 7 ITEM 1B. Unresolved Staff Comments 13 ITEM 2. Properties 13 ITEM 3. Legal Proceedings 13 ITEM 4. Mine Safety Disclosures 13 PART II ITEM 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 14 ITEM 6. Selected Financial Data 14 ITEM 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 14 ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk 23 ITEM 8. Financial Statements and Supplementary Data 24 ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 24 ITEM 9A. Controls and Procedures 24 ITEM 9B. Other Information 25 PART III ITEM 10. Directors, Executive Officers and Corporate Governance 26 ITEM 11. Executive Compensation 26 ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 26 ITEM 13. Certain Relationships and Related Transactions, and Director Independence 26 ITEM 14. Principal Accounting Fees and Services 26 PART IV ITEM 15. Exhibits and Financial Statement Schedules 27 SIGNATURES 28 Table of Contents PART I When used in this report, the terms "Summer," the "Company," "we," "us," and "our" mean Summer Infant, Inc. and its subsidiaries. Note that all dollar amounts in Part I are in thousands of U.S. dollars unless otherwise noted. Item 1. Business Overview We are a premier juvenile products company originally founded in 1985 and have publicly traded on the Nasdaq Stock Market since 2007 under the symbol "SUMR." We create branded juvenile safety and infant care products (targeted for ages 0-3 years) that are intended to deliver a diverse range of parenting solutions to families. We focus on providing innovative products to meet the lifestyle and demands of families who seek more opportunities to connect with their children. We operate in one principal industry segment across geographically diverse marketplaces, selling our products globally to large, national retailers as well as independent retailers, and on the internet through third-party websites and our own www.SummerInfant.com website. In North America, our customers include Babies R Us, Wal-Mart, Target, Amazon.com, Buy Buy Baby, Burlington Coat Factory, Kmart, Home Depot, and Lowe's. Our largest European-based customers are Mothercare, Toys R Us, Argos and Tesco. We also sell through international distributors, representatives, and to select international retail customers in geographic locations where we do not have a direct sales presence. The juvenile products industry is estimated to be a $20 billion market worldwide, and consumer focus is on quality, safety, innovation, and style. Due to the halo effect of baby products in retail stores, there is a strong retailer commitment to the juvenile category. We believe we are positioned to capitalize on positive market trends in the juvenile products industry, including a predicted increase in U.S. birth rates over the next several years. Strategic Priorities We seek to become a global, leading juvenile company by providing a full range of innovative, high quality, high value products that meet the demands of parents. We have identified the following key strategic priorities that we believe will support our future growth: • Continue to innovate. We continuously seek to create innovative solutions for consumers whose lifestyles demand high quality, long lasting, and safe products. We believe the nursery of the future will be a "connected" nursery, providing parents with continual access to information about their child. To the extent it is consistent with our strategy, we may collaborate with third parties in developing new products or acquiring new products. In 2014, we increased availability of our innovative Link WiFi Series of internet viewable monitors, introduced our Pop 'n Play Portable Playard, and expanded our popular new line of 3D lite TM convenience strollers. • Increase consumer connectivity with our Company. We focus our efforts getting to know our consumers' routines and lifestyles. Our in-depth knowledge of their needs allows us to deliver high quality, innovative products to the marketplace. Through focus groups, on-line surveys, and test marketing, we continually evaluate consumer reactions to our products. We take a strategic approach to setting price points, which provide us the opportunity to create products that appeal to different categories of end consumers and classes of trade. We also seek to improve the customer experience in stores and online. In 2014, we introduced our safety gate selector tool, which is intended to aid consumers in selecting the correct baby gate for their needs and simplify the in-store and online retail experience. We also expect to continue to increase our social media presence and the capabilities of our website to further connect consumers with our brands. Table of Contents • Increase awareness of our brands. Historically, we marketed products under our own brands, under license agreements for other brands, and under private label agreements. In 2013 and 2014, we began to shift our focus to strengthening our strong portfolio of core brands of Summer®, the company that cares and strives to make parenting worry free, SwaddleMe®, the premier resource for safe sleep, and Born Free®, with nurturing support for healthy families. We will continue to focus our marketing efforts on increasing brand recognition and brand loyalty and increasing our engagement with our customers, particularly first-time, prenatal moms. • Maintain and grow our partnerships. We have long-standing relationships and strong partnerships with our retail customers and strong relationships with suppliers that provide us the flexibility needed to engineer our products in a cost-efficient manner and to respond quickly to customer demands. We will continue to focus on strengthening these existing relationships to increase our presence in stores, online and in new geographic locations. In specialty retail, we are adding retailers and distributors to target markets where we do not currently have a presence. In December 2014, we announced a co-branding partnership with Little Me® for our SwaddleMe® wearable blankets, which we believe will expand our channel distribution to top tier department stores and specialty retailers. In addition, we are continuing to expand our business internationally. By focusing on these key strategic priorities, we expect to drive future sales growth, improve profitability and our return on capital, and further develop and strengthen our relationships with our suppliers, our customers and the consumers who use our products. Products We currently market over 1,100 products in several product categories including monitoring, safety, nursery, baby gear, and feeding products. Our portfolio of strong brands, under which we market all of our core products, includes Summer®, Born Free®, and SwaddleMe®. No single product generated more than 10% of sales for the 2014 fiscal year ended January 3, 2015 ("fiscal 2014"). Anchor products in our product categories include the following: Monitoring Our monitors were first introduced in 2001 and are characterized by premium quality, ease of use, and innovative features. Currently, we offer audio, video, and internet viewable monitors, marketed under the Summer® brand. Our monitors feature high quality components, intended to fulfill the desire for consumers to connect with baby at any time or place. In 2014, we increased availability of our Link WiFi Series of internet viewable monitors, and in 2015, we expect to launch our WiFi 3.0 hi-definition monitor. Safety Our safety line encompasses gates and home safety products, potties, bath, positioners, and infant health. We are a North American market leader in the gate category, with a product range of 30 gates covering all key consumer price points. In 2014, we introduced an innovative retail merchandising solution, a safety gate selector tool. This online tool was initially created to facilitate selection of a 2 Monitoring Safety Nursery Baby Gear Feeding Products Wi-Fi/Internet Gates Swaddle Strollers Bottles Video Bath Travel Accessories Bassinets Drinking Cups Audio Potties Safe Sleep High Chairs Bibs & Placemats Boosters Soothers Playards Electronics Super Seats Pacifiers Table of Contents safety gate to meet the particular needs of the consumer with regard to space (size and location) as well as installation considerations (bannisters, baseboards, walls), and reduce the number of returned or damaged goods. Its success led us to further develop the selector for our retailers as an in-store sales tool and merchandising solution. We also launched our "HomeSafe by Summer" line of home safety products, which presents an increased opportunity to expand distribution into the home center and pet care channels. We first entered the infant bathing category in 2002, and we have continued to create innovative and safe solutions for bathing baby. In 2014, we introduced several new platforms developed as the result of consumer insights, including the Keep Me Warm Baby Bath, which is designed to increase baby's comfort by delivering a warm flow of water over baby's back during bath time. Nursery Our nursery line includes our core brand of SwaddleMe® wearable blankets as well as travel accessories, soothers, and bedding. Acquired in 2008, SwaddleMe® continues to be a brand synonymous with safe sleep among consumers. In 2015, we will be undertaking a brand refresh of this popular line as we continue to expand our channels of trade as well as our selection of product in this growing category. In late 2014, we announced our co-branded partnership with Little Me®, a premier newborn and infant clothing brand. The new co-branded product line is expected to launch in mid-2015 and provides us with the opportunity to broaden the presence of the SwaddleMe®, brand into high-end department stores and premium specialty retailers. Baby Gear Since the introduction of the Bouncy Seat in 1985, our first product, we have expanded our baby gear category to include high chairs, playards, bassinets, and strollers. Following on the success of our 3D lite TM Convenience Stroller in 2014, we are expanding this line in 2015 with lightweight, affordable, feature rich strollers including the 3D-one, 3D flip and 3D zyre. Our Pop 'n Play Portable Playard was introduced to market in 2014 driven from consumer insights on their "on-the-go" lifestyles. Compact, foldable, lightweight and portable, the Pop 'n Play Portable Playard has been well received, and we continue to expand the product into new channels and markets. Feeding Products We acquired the Born Free® brand in 2011 to provide calm, safe feeding solutions. The premium Born Free® Bottle continues to be the core product in the feeding category that has evolved to include pacifiers, drinking cups, bibs, and electronics. In 2015, we are launching Bottle Genius TM , a one stop-station that prepares a bottle in seconds at the optimum temperature, ready to serve to baby. In conjunction with the introduction of exciting new products, our Born Free® line will also be undertaking a brand refresh in order to continue to meet our mission to help healthy families grow with fewer worries and more smiles. Product Development and Design Innovation drives out product development, a critical element of our strategy. We strive to produce proprietary products that offer distinctive benefits, are visually appealing, and provide caring solutions to the consumer. Our retail customers are strategically motivated to buy innovative products to provide differentiation from their competitors. We design the majority of our own products at our Rhode Island headquarters. We also have development efforts in China and the United Kingdom. If consistent with our strategy, we may also 3 Table of Contents collaborate with third parties in the development of products, license technologies or acquire new products from third parties. In addition to new product development, we continuously look for ways to improve upon existing products based on consumer insights with a strong focus on the end-user experience and product safety. New product introductions provide opportunities for improved pricing and product margins. We engage in market research and test marketing to evaluate consumer reactions to our products, both pre- and post-production. Our product development team and sales force are essential in researching consumer buying trends and analyzing information from retail stores, customer surveys, focus groups, on-line surveys, industry experts and vendor recommendations. We continually evaluate our products to determine whether they should be upgraded, modified, or discontinued. Suppliers and Manufacturing Substantially all of our products are manufactured in Asia (primarily China) and Israel. We also use several manufacturers in the United States for certain injection-molded products, including bath tubs, potty seats and booster seats, which together account for approximately 14% of our annual sales in 2014. We are not dependent on any one supplier because we use many different manufacturers and we own the tooling and molds used for our products. Our Hong Kong subsidiary provides us with a local sourcing presence and the ability to oversee quality, electronic engineering and other issues that may arise during production. Generally, we buy finished goods from manufacturers, and thus are not directly procuring raw materials for product manufacturing. Historically, we have not experienced any significant disruption of supply as a result of raw material shortages or other manufacturing factors, but there is the possibility that shortages could occur in the future based on a variety of factors beyond our control. Transportation of Asia-made goods to our warehouses typically takes three to four weeks, depending on the location of the warehouse. We also utilize a direct import program, to reduce costs and shipping time to certain customers. We maintain our inventory at warehouses located in the United States, Canada, Australia, and the United Kingdom. Most of our customers pick up their goods at regional warehouses. We also use UPS and other common carriers to arrange shipments to customers (primarily smaller retailers and specialty stores) that request such arrangements. Sales and Marketing Our products are largely marketed and sold through our own direct global sales force of industry experienced professionals. We have also established a strong network of independent manufacturers' representatives and distributors to provide sales and customer service support for the remaining portion of North American and international sales. E-commerce sales have continued to grow during recent years consistent with increased online shopping by consumers. Sales are recognized upon transfer of title of product to our customers and are made utilizing standard credit terms of 30 to 60 days. We generally accept returns only for defective merchandise. Marketing, promotion and consumer education are key elements in the juvenile products industry. Historically, a significant percentage of our promotional spending has been structured in coordination with our large retail partners. In 2014, we focused more of our spending on awareness and outreach programs to both our retail partners and our end-use consumers. In further support of this communication effort, we continue to improve the functionality and capabilities of our website and develop merchandising solutions to improve the overall experience for consumers. 4 Table of Contents In addition, we will continue to support the promotion and presence of Summer®, SwaddleMe®, and Born Free® branded products in the marketplace with continued participation at select industry trade shows, trade and consumer advertising, as well as enhanced internet-based promotional activities. Customer service is a critical component of our marketing strategy. We maintain an internal customer service department that responds to customer inquiries, investigates and resolves issues, and generally assists customers and consumers on a 24/7 basis. Competition The juvenile product industry has many participants, none of which have dominant market share, though certain companies may have disproportionate strength in certain product categories. We compete with a number of different companies in a variety of categories, although there is no single company that competes with us across all of our product categories. Our largest direct competitors are Dorel Industries (including Safety 1st and Cosco brands), Fisher-Price (part of Mattel, Inc.), The First Years (a subsidiary of Tomy Corporation), and Graco (a subsidiary of Newell Rubbermaid). In addition, we compete in several of our product lines with a number of private companies, such as KidCo, Inc. and Munchkin. The primary methods of competition in the industry consist of product innovation, brand positioning, quality, price, and timely distribution. Our competitive strengths include our ability to develop innovative new products, brand awareness, our relationships with major retailers, and the quality and pricing of our products. Intellectual Property We rely on a combination of patents, licenses and trade secrets to protect our intellectual property. Our patents currently in effect include various design features related to safety gates, bouncers, and bathers, with several other patents under review by the United States Patent and Trademark Office (USPTO). These patents expire at various times during the next 17 years. Our focus on continuous product improvement and innovation provides constant strength and renewal of our patent portfolio. We also have license agreements in place related to the use of patented technology owned by third parties in certain of our products. In certain circumstances, if we do not believe we have appropriate expertise, we will partner with third parties to develop proprietary products. Customers Sales to our top seven customers together comprised more than 74% of our sales in fiscal 2014 and 78% of our sales in fiscal 2013. These customers include Babies R Us/Toys R Us, Wal-Mart, Target, Amazon.com, Buy Buy Baby, K-Mart, and Burlington Coat Factory. Of these customers, four generated more than 10% of sales for fiscal 2014: Babies R Us/Toys R Us (27%), Walmart (14%), Target (11%), and Amazon.com (11%). In fiscal 2013, three customers generated more than 10% of sales: Babies R Us/Toys R Us (31%), Walmart (19%) and Target (11%). We have no long-term contracts with these customers, and because of the concentration of our business with these customers, our success depends heavily on our customers' willingness to purchase and provide shelf space for our products. Seasonality We do not see significant variations in seasonal demand for our products. Sales history has exhibited some higher volume at times associated with initial shipments of new products. These orders usually incorporate enough product inventory to fill each store plus additional amounts to be kept at the customer's distribution center. The timing of these initial shipments varies by customer depending on when they finalize store layouts for the upcoming year and whether there are any mid-year product introductions. 5 Table of Contents Geographic Regions North America accounted for approximately 91% and 92% of our total net sales in 2014 and 2013, respectively. Remaining sales were in the United Kingdom and all other geographic regions. We maintain sales, marketing, and distribution offices in Canada, Australia, and England, which services the United Kingdom and other parts of Europe. We also maintain a product development, engineering and quality assurance office in Hong Kong. Regulatory Matters We obtain all necessary regulatory agency approvals for each of our products. In the United States, these approvals may include, among others: Consumer Product Safety Commission ("CPSC"), the American Society of Test Methods ("ASTM"), the Juvenile Products Manufacturing Association ("JPMA"), the Federal Communications Commission ("FCC") and the U.S. Food and Drug Administration ("FDA"). We conduct our own internal testing, utilizing a "foreseeable use and abuse" testing method that is designed to subject each product to the "worst case scenario." Our products are also frequently tested by independent government certified labs. Insurance We carry product liability insurance that provides us with $15 million coverage with a minimal deductible. We consult with our insurers to ascertain appropriate liability coverage for our product mix. We believe our current coverage is adequate for our existing business and will continue to evaluate our coverage in the future in line with our expanding sales and product breadth. Employees As of January 3, 2015, we had approximately 203 employees, 198 who were full time employees, and 118 of whom work in our headquarters in Rhode Island. Our employees are not covered by a collective bargaining agreement. We consider our employee relations to be good. Available Information The Company is incorporated under the laws of the State of Delaware. Our principal executive offices are located at 1275 Park East Drive, Woonsocket, Rhode Island 02895, and our telephone number is (401) 671 6550. We maintain our corporate website at www.summerinfant.com and we make available, free of charge, through this website our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports that we file with, or furnish to, the Securities and Exchange Commission ("SEC"), as soon as reasonably practicable after we electronically file that material with, or furnish it to, the SEC. You may also read and copy any material filed by us with the SEC at the SEC's Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549, and you may obtain information on the operation of the Public Reference Room by calling the SEC in the U.S. at 1-800-SEC-0330. In addition, the SEC maintains an Internet website, www.sec.gov, that contains reports, proxy and information statements and other information that we file electronically with the SEC. Our website also includes corporate governance information, including our Code of Ethics and our Board Committee Charters. The information contained on our website does not constitute a part of this report. 6 Table of Contents Item 1A. Risk Factors If any of the events or circumstances described in the following risks actually occur, our business, financial condition or results of operations could be materially adversely affected and the trading price of our common stock could decline. The concentration of our business with a base of retail customers means that economic difficulties or changes in the purchasing policies of our major customers could have a significant impact on our business and operating results. We rely on a relatively small base of retail customers to sell the majority of our products. In fiscal 2014, Babies R Us/Toys R Us generated 27% of our total sales, three other customers each accounted for more than 10% of our sales, and seven customers accounted for 74% of our total sales. If one or more of these customers were to experience difficulties in fulfilling their obligations to us, cease doing business with us, significantly reduce the amount of their purchases from us, favor competitors, increase their direct competition with us by expanding their private-label business, change their purchasing patterns, change the manner in which they promote our products, or return a substantial amount of our products, it could significantly harm our sales, profitability and financial condition. The sales we make to customers are typically made on credit without collateral. There is a risk that key customers will not pay or that payment may be delayed, because of contraction of credit availability to such customers, weak retail sales or other factors beyond our control, which could increase our exposure to losses from bad debts. In addition, if key customers were to cease doing business or significantly reduce the number of stores operated, it could have a significant adverse effect on our business, financial condition, and results of operations. We do not have long-term commitments with any of our retail customers, and retailers make purchases by delivering one-time purchase orders. As a result, pricing, shelf space, cooperative advertising or promotions with each retailer may be subject to change and periodic negotiation. We have no long- term contracts with our retail customers and, because of the significant concentration of our business with these customers, our success depends on our customers' willingness to continue to purchase our products and provide advertising and promotion support and shelf space for our products. An adverse change in our relationship with any of our significant retail customers could adversely affect our results of operations and financial condition. Our ability to grow and compete will be harmed if we do not successfully satisfy consumer preferences, enhance existing products, develop and introduce new products, and achieve market acceptance of those products. Our business and operating results depend largely upon providing our customers products that appeal to the end user. Consumer preferences, particularly among parents whom are often the end purchasers of our products, are constantly changing. Our success largely depends on our ability to identify emerging trends in the infant and juvenile health, safety and wellness marketplace, and to design quality products that address consumer preferences and prove safe and cost effective. Our product offerings compete with those of many other larger companies. Many of these companies enjoy broader brand recognition and have significant distribution channel relationships in place, and as a result, our market position is always at risk. Our ability to maintain and increase our current market share will depend upon our ability to anticipate changes in consumer preferences and satisfy these preferences, enhance existing products, develop and introduce new products and establish and grow distribution channels for these products, and ultimately, achieve market acceptance of these products. A failure to achieve market acceptance of our products would harm our ability to grow our business. 7 Table of Contents An inability to develop and introduce planned new products or product lines in a timely and cost-effective manner may damage our business. In developing new products and product lines, we have anticipated dates for the associated product introductions. When we state that we will introduce, or anticipate introducing, a particular product or product line at a certain time in the future, those expectations are based on completing the associated development, implementation, marketing work, and manufacturing in accordance with our currently anticipated development schedule. The risk is also heightened by the sophistication of certain products we are designing, in terms of combining digital and analog technologies, utilizing digital media to a greater degree, and providing greater innovation and product differentiation. Unforeseen delays or difficulties in the development process, significant increases in the planned cost of development, changes in anticipated consumer demand for our products, and delays in the manufacturing process may cause the introduction date for products to be later than anticipated or, in some situations, may cause a product introduction to be discontinued. If we are unable to manufacture, source and ship new products in a timely manner and on a cost effective basis to meet constantly changing customer demand, it could have a material adverse effect on our business and operating results. If we do not maintain sufficient inventory levels or if we are unable to deliver our products to our customers in sufficient quantities, or on a timely basis, or if our inventory levels are too high, our operating results will be adversely affected. Our business places stringent demands on our inventory forecasting and production planning processes. This inventory management approach may be particularly challenging when combined with "just-in-time" inventory management systems commonly used by retailers to minimize their inventory levels. If we fail to meet tight shipping schedules, we could damage our relationships with retailers, increase our shipping costs or cause sales opportunities to be delayed or lost. To deliver our merchandise on a timely basis, we need to maintain adequate inventory levels of the desired products. This approach requires us to begin to place orders for components for certain products up to a year in advance, and we procure a significant amount of product months in advance of certain time periods. At the time we place factory orders, we may not have firm orders from retailers or a complete understanding of what consumer demand for those products will be. If our inventory forecasting and production planning processes result in manufacturing inventory levels in excess of the levels demanded by our customers, we could be required to record inventory write-downs for excess and obsolete inventory, which would adversely affect our operating results. In addition, if our processes result in our inventory levels being too low to meet customer demand, we may lose sales, which would adversely affect our operating results. We rely on external financing to help fund our operations. Covenants in our debt agreements may affect our liquidity or limit our ability to complete acquisitions, incur debt, make investments, sell assets, merge or complete other significant transactions. To meet our working capital needs, we rely on our revolving credit facility for working capital. Our credit facility agreement includes certain covenants that place limitations on or restrict a number of our activities, including our ability to: • incur additional debt; • create liens on our assets or make guarantees; • make certain investments or loans; • pay dividends; or • dispose of or sell assets; or 8 Table of Contents • enter into a merger or similar transaction. Our performance and financial condition may not meet our original expectations at the time we entered into the credit facility, causing us to fail to meet such financial covenants. These restrictive covenants may limit our ability to engage in acts that may be in our best long-term interests. Non-compliance with the covenants in these agreements could result in us being unable to utilize borrowings under our revolving credit facility, a circumstance which potentially could occur when operating shortfalls would most require supplementary borrowings to enable us to continue to fund our operations. There is no guarantee that we would be able to refinance debt on favorable terms, or at all. Deviations from expected results of operations and expected cash requirements could result in a failure to meet financial covenants under our debt agreements, which would adversely affect our financial condition and results of operations. Any significant deviation in actual results from our expected results of operations, or in the timing of material expenditures from current estimates, any significant business or product acquisitions, or other significant unanticipated expenses could result in us not meeting our financial covenants under the terms of our credit facility and term loan. If we are unable to generate sufficient available cash flow to service our outstanding debt, then we would need to refinance such debt or face default. In such circumstances, our lenders could declare a default, which would have a material adverse effect on our financial condition and results of operations. If access to our credit facility is limited or terminated, our liquidity would be constrained, affecting our operations and growth prospects, and we would need to seek additional equity or debt financing. There is no assurance that such financing would be available on acceptable terms or at all. Furthermore, any equity financing may result in dilution to existing stockholders and any debt financing may include restrictive covenants that could impede our ability to effectively operate and grow our business in the future. The intense competition in our markets could reduce our net sales and profitability. We operate in a highly competitive market and compete with several large domestic and foreign companies and with other producers of infant and juvenile products. Many of our competitors have longer operating histories, greater brand recognition, and greater financial, technical, marketing and other resources than us. In addition, we may face competition from new participants in our markets because the infant and juvenile product industry has low barriers to entry. We experience price competition for our products and competition for shelf space at retailers, all of which may increase in the future. If we cannot compete successfully in the future, our net sales and profitability will likely decline. We rely on foreign suppliers in Asia to manufacture the majority of our products, and any adverse change in our relationship with our suppliers could harm our business. We rely on numerous third-party suppliers located in Asia for the manufacture of most of our products. While we believe that alternative suppliers could be located if required, our product sourcing could be affected if any of these suppliers do not continue to manufacture our products in required quantities or at all, or with the required levels of quality. We do not have any long-term supply contracts with our foreign suppliers; rather, we enter into purchase orders with these suppliers. In addition, difficulties encountered by these suppliers, such as fire, accident, natural disasters, outbreaks of contagious diseases, or political unrest, could halt or disrupt production at the affected locations, resulting in delay or cancellation of orders. Any of these events could result in delayed deliveries by us of our products, causing reduced sales and harm to our reputation and brand name. 9 Table of Contents Because we rely on foreign suppliers and we sell in foreign markets, we are subject to numerous risks associated with international business that could increase our costs or disrupt the supply of our products, resulting in a negative impact on our business and financial condition. Our international operations subject us to risks, including: • economic and political instability; • restrictive actions by foreign governments; • greater difficulty enforcing intellectual property rights and weaker laws protecting intellectual property rights; • changes in import duties or import or export restrictions; • timely shipping of product and unloading of product through West Coast ports, as well as timely truck delivery to our warehouses; • complications in complying with the laws and policies of the United States affecting the importation of goods, including duties, quotas, and taxes; and • complications in complying with trade and foreign tax laws. Any of these events or circumstances could disrupt the supply of our products or increase our expenses. Because of the importance of our international sourcing of manufacturing to our business, our financial condition and results of operations could be significantly harmed if any of the risks described above were to occur or if we are otherwise unsuccessful in managing our global operations. Increases in the cost of materials or labor used to manufacture our products could decrease our profitability and therefore negatively impact our business and financial condition. Because our products are manufactured by third-party suppliers, we do not directly purchase the materials used in the manufacture of our products. However, the prices paid by us to these suppliers could increase if raw materials, labor, or other costs increase. If we cannot pass these increases along to our customers, our profitability will be adversely affected. Intellectual property claims relating to our products could increase our costs and adversely affect our business. We have, from time to time, received claims of alleged infringement of patents relating to certain of our products, and we may face similar claims in the future. These claims relate to alleged patent infringement and are primarily the result of newly-issued patents that were not in force when we initially brought the subject products to market. The defense of intellectual property claims can be costly and time consuming, even in circumstances where the claim is without merit. We may be required to pay substantial damages or settlement costs in order to resolve these types of claims. In addition, these claims could materially harm our brand name, reputation and operations. Product liability, product recalls, and other claims relating to the use of our products could increase our costs. Because we produce infant and juvenile health, safety and wellness consumer products, we face product liability risks relating to the use by consumers of our products. We also must comply with a variety of product safety and product testing regulations. In particular, our products are subject to the Consumer Product Safety Act, the Federal Hazardous Substances Act ("FHSA") and the Consumer Product Safety Improvement Act ("CPSIA"), which empower the Consumer Product Safety Commission (the "CPSC"), to take action against hazards presented by consumer products. With expanded authority under the CPSIA, the CPSC has and continues to adopt new regulations for safety and products testing that apply to our products. These new regulations have or likely will significantly increase the regulatory requirements governing the manufacture and sale of children's products and increase the 10 Table of Contents potential penalties for noncompliance with applicable regulations. The CPSC has the authority to exclude from the market and recall certain consumer products that are found to be potentially hazardous. Consumer product safety laws also exist in some states and cities within the United States and in Canada and Europe, as well as certain other countries. If we fail to comply with these laws and regulations, or if we face product liability claims, we may be subject to damage awards or settlement costs that exceed any available insurance coverage and we may incur significant costs in complying with recall requirements. We maintain a quality control program to help ensure compliance with applicable product safety requirements. Nonetheless, we have experienced, and may in the future experience, issues in products that may lead to product liability, personal injury or property damage claims, recalls, withdrawals, replacements of products, or regulatory actions by governmental authorities. A product recall could have a material adverse effect on our results of operations and financial condition, depending on the product affected by the recall and the extent of the recall efforts required. A product recall could also negatively affect our reputation and the sales of other products. Furthermore, concerns about potential liability may lead us to recall voluntarily selected products. For instance, in April 2014, we initiated a recall of rechargeable batteries in certain of our handheld video monitors, and in 2011, we undertook voluntary action to re-label our audio/video nursery monitors and recorded a charge in connection with the settlement of outstanding litigation related to our analog video nursery monitors. Complying with existing or any such additional regulations or requirements could impose increased costs on our business operations, decrease sales, increase legal fees and other costs, and put us at a competitive disadvantage compared to other manufacturers not affected by similar issues with products, any of which could have a significant adverse effect on our financial condition. Similarly, increased penalties for non-compliance could subject us to greater expense in the event any of our products were found to not comply with such regulations. We are dependent on key personnel, and our ability to grow and compete in our industry will be harmed if we do not retain the continued services of our key personnel, or we fail to identify, hire, and retain additional qualified personnel. Our success depends on the efforts of our senior management team and other key personnel. Although we believe that we have a strong management team, the loss of services of members of our senior management team, who have substantial experience in the infant and juvenile health, safety and wellness markets, could have an adverse effect on our business. In addition, if we expect to grow our operations, it will be necessary for us to attract and retain additional qualified personnel. The market for qualified and talented product development personnel in the consumer goods market, and specifically in the infant and juvenile health, safety and wellness products market, is intensely competitive. If we are unable to attract or retain qualified personnel as needed, the growth of our operations could be slowed or hampered. We may have exposure to greater than anticipated tax liabilities, that, if not identified, could negatively affect our consolidated operating results and net worth. Our provision for income taxes is subject to volatility and could be adversely affected by nondeductible equity-based compensation, earnings being lower than anticipated in jurisdictions where we have lower statutory rates and being higher than anticipated in jurisdictions where we have higher statutory rates, transfer pricing adjustments, not meeting the terms and conditions of tax holidays or incentives, changes in the valuation of our deferred tax assets and liabilities, changes in actual results versus our estimates, or changes in tax laws, regulations, accounting principles or interpretations thereof, and taxes relating to deemed dividends resulting from foreign guarantees made by certain of our foreign subsidiaries. In addition, like other companies, we may be subject to examination of our income tax returns by the U.S. Internal Revenue Service and other tax authorities. While we regularly 11 Table of Contents assess the likelihood of adverse outcomes from such examinations and the adequacy of our provision for income taxes, there can be no assurance that such provision is sufficient and that a determination by a tax authority will not have an adverse effect on our results of operations. A material impairment in the carrying value of acquired goodwill or other intangible assets could negatively affect our consolidated operating results and net worth. A portion of our assets are intangible, which are reviewed on an annual basis and whenever events and changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the carrying value of these assets exceeds the current fair value, the asset is considered impaired and is reduced to fair value, resulting in a non-cash charge to earnings during the period in which any impairment is determined. Events and conditions that could result in impairment include a sustained drop in the market price of our common stock, increased competition or loss of market share, product innovation or obsolescence, or a decline of our business related to acquired companies. We cannot accurately predict the amount and timing of any future impairment of assets. We may experience difficulties in identifying suitable acquisition targets and integrating strategic acquisitions. In the past, we have made strategic acquisitions and continue to pursue acquisitions that are consistent with our business strategy and enable us to leverage our competitive strengths. While we continue to evaluate potential acquisitions, we may not be able to identify and successfully negotiate suitable acquisitions, obtain financing for future acquisitions on satisfactory terms, obtain regulatory approval for certain acquisitions or otherwise complete acquisitions in the future. An inability to identify future acquisitions could limit our future growth. The integration of operations of any company we do acquire involves a number of risks, including unanticipated costs relating to the integration of acquired business, difficulties in achieving planned cost-savings and synergies and the diversion of management's attention to integration could impair their ability to effectively manage our current business operations. In addition, any future acquisition may result in issuances of dilutive equity securities, which may be sold at a discount to market price, the incurrence of debt, unfavorable financing terms, large one-time expenses and the creation of intangible assets, including goodwill, the write-down of which may result in significant charges to earnings. We rely on information technology in our operations, and any material failure, inadequacy, interruption, or security failure of that technology could harm our ability to effectively operate our business. We rely on information technology systems across our operations, including for management of our supply chain, sale and delivery of our products, and various other processes and transactions, including credit card processing for online sales. Our ability to effectively manage our business and coordinate the production, distribution, and sale of our products depends on the reliability and capacity of these systems and in some instances, third-party service providers. The failure of these systems to operate effectively due to service interruptions, problems with transitioning to upgraded or replacement systems, or a breach in security of these systems could cause delays in product sales and reduced efficiency of our operations, loss of proprietary data or customer information, and capital investments could be required to remediate the problem. Our stock price has been and may continue to be volatile. The market price of our common stock has been, and is likely to continue to be, volatile. When we or our competitors announce new products, experience quarterly fluctuations in operating results, announce strategic relationships, acquisitions or dispositions, change earnings estimates, published financial results or other material news, our stock price is often affected. The volatility of our stock price may be accentuated during periods of low volume trading, which may require a stockholder 12 Table of Contents wishing to sell a large number of shares to do so in increments over time to mitigate any adverse impact of the sales on the market price of our stock. Anti-takeover provisions in our organizational documents and Delaware law may limit the ability of our stockholders to control our policies and effect a change of control of our Company and may prevent attempts by our stockholders to replace or remove our current management, which may not be in your best interests. There are provisions in our certificate of incorporation and bylaws that may discourage a third party from making a proposal to acquire us, even if some of our stockholders might consider the proposal to be in their best interests, and may prevent attempts by our stockholders to replace or remove our current management. These provisions include provisions in our certificate of incorporation that authorize our Board of Directors to issue shares of preferred stock without stockholder approval and to establish the preferences and rights of any preferred stock issued, which would allow the Board of Directors to issue one or more classes or series of preferred stock that could discourage or delay a tender offer or change in control, and provisions in our bylaws that require advance written notice of stockholder proposals and director nominations. Additionally, we are subject to Section 203 of the Delaware General Corporation Law, which, in general, imposes restrictions upon acquirers of 15% or more of our stock. Finally, the Board of Directors may in the future adopt other protective measures, such as a stockholder rights plan, which could delay, deter or prevent a change of control. Item 1B. Unresolved Staff Comments None. Item 2. Properties We are headquartered in a 52,000 square facility in Woonsocket, Rhode Island. We have a seven year lease on this facility, which will expire in 2016, and includes an option to extend the lease for an additional five-year term. We also lease small offices in Arkansas, Canada, Israel, the United Kingdom and Hong Kong. We maintain inventory at leased warehouses in California (approximately 442,000 square feet), Canada (approximately 61,000 square feet), Australia (third party warehouse) and the United Kingdom (approximately 16,000 square feet). These leases expire at various times through 2018. Item 3. Legal Proceedings From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may have a material adverse effect on our business, financial condition or results of operations. Item 4. Mine Safety Disclosures Not applicable. 13 Table of Contents PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Price Range of Common Stock Our common stock is traded on the Nasdaq Capital Market under the symbol "SUMR". The high and low sales prices for our common stock as reported on the Nasdaq Capital Market for the periods indicated below were as follows: Holders of Common Stock As of January 23, 2015, there were 33 holders of record of our common stock. Because shares of our common stock are held by depositaries, brokers and other nominees, the number of beneficial holders of our shares is substantially larger than the number of record holders. Dividend Policy There have been no cash dividends declared on our common stock since our Company was formed. Dividends are declared at the sole discretion of our Board of Directors. Our intention is not to declare cash dividends and retain all cash for our operations and future acquisitions. In addition, under the terms of our current credit facilities, we are restricted in our ability to pay cash dividends to our stockholders. Issuer Repurchases of Equity Securities None. Recent Sales of Unregistered Securities Not applicable. Item 6. Selected Consolidated Financial Data Not required. Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion is intended to assist in the assessment of significant changes and trends related to our results of operations and financial condition. The information contained in this section has been derived from our consolidated financial statements and should be read together with our consolidated financial statements and related notes included elsewhere in this report. Readers should 14 High Low Fiscal Year Ended December 31, 2013 First Quarter $ 2.79 $ 1.67 Second Quarter $ 3.73 $ 2.22 Third Quarter $ 3.60 $ 2.66 Fourth Quarter $ 3.05 $ 1.71 Fiscal Year Ended January 3, 2015 First Quarter $ 2.37 $ 1.45 Second Quarter $ 3.50 $ 1.60 Third Quarter $ 4.77 $ 2.71 Fourth Quarter $ 3.64 $ 1.74 Table of Contents also review and consider our disclosures under the heading "Special Note Regarding Forward-Looking Statements" describing various factors that could affect our business and the disclosures under the heading "Risk Factors" in this report. Note that all dollar amounts in this Item 7 are in thousands of U.S. dollars, except share and per share data. In 2014, our Board of Directors approved a change in our fiscal year, from a fiscal year ending on December 31 of each calendar year to a fiscal year ending on the Saturday closest to December 31 of each calendar year. This change is effective with the 2014 fiscal year. As a result our 2014 fiscal year ended on January 3, 2015. The change in fiscal year did not have a material impact on our results for fiscal 2014 and did not materially impact the comparison of fiscal 2014 results to fiscal 2013 results discussed below. For purposes of this discussion, fiscal 2014 means the fiscal year ended January 3, 2015, fiscal 2013 means the fiscal year ended December 31, 2013. Overview We are a premier juvenile products company originally founded in 1985 and have publicly traded on the Nasdaq Stock Market since 2007 under the symbol "SUMR." We create branded juvenile health, safety and wellness products (targeted for ages 0-3 years) that are intended to deliver a diverse range of parenting solutions to families. We focus on providing innovative products to meet the "on-the-go" lifestyle and demands of families who seek more opportunities to connect with their children. We operate in one principal industry segment across geographically diverse marketplaces, selling our products globally to large, national retailers as well as independent retailers, and on the internet through third-party websites and our own corporate website. In North America, our customers include Babies R Us, Wal-Mart, Target, Amazon.com, Buy Buy Baby, Burlington Coat Factory, Kmart, Home Depot, and Lowe's. Our largest European-based customers are Mothercare, Toys R Us, Argos and Tesco. We also sell through international distributors, representatives, and to select international retail customers in geographic locations where we do not have a direct sales presence. The juvenile products industry is estimated to be a $20 billion market worldwide, and consumer focus is on quality, safety, innovation, and style. Due to the halo effect of baby products in retail stores, there is a strong retailer commitment to the juvenile category. We believe we are positioned to capitalize on positive market trends in the juvenile products industry, including a predicted increase in U.S. birth rates over the next several years. Fiscal 2014 was a transformative year for our Company. We made several changes in executive leadership, including the appointment of Carol E. Bramson, a member of our Board of Directors, as our Chief Executive Officer in February 2014. We also added several key members to our senior management team during 2014, including Ken Price as our President of Global Sales, Ronald T. Cardone as our Senior Vice President, Information Technology, and Anna Dooley joined us as Senior Vice President of Product Development. In late 2014, William E. Mote, Jr. was appointed our Chief Financial Officer and in March 2015, we announced the appointment of Robert Stebenne as our President and Chief Operating Officer. In addition, we substantially completed the process of exiting our licensing arrangements with Disney® and Carters® begun in 2013 to focus on building our own Summer®, SwaddleMe®, and Born Free® branded products. As a result of exiting these arrangements, net sales in fiscal 2014 were lower than fiscal 2013 while gross profit increased in fiscal 2014, reflecting the benefit of decreased sales of lower margin licensed, closeout and promotional product sales in fiscal 2014 as compared to fiscal 2013. In April 2014, we announced a voluntary recall of rechargeable batteries in certain of our handheld video monitors. Costs associated with the recall were approximately $300, including shared costs from 15 Table of Contents our monitor manufacturer. The shared costs were taken as a charge to our cost of goods sold in the first quarter of 2014. We do not expect the recall to have a significant effect on 2015. In 2014, we introduced several new products, including our Pop 'n Play Portable Playard, 3D lite™ Convenience Strollers and Bottle Genius™ Formula Dispenser. We also launched HomeSafe by Summer, a line of home safety products, and in late 2014, we announced our co-branded partnership with Little Me®, a premier newborn and infant clothing brand. The new co-branded product line is expected to launch in mid-2015 and provides us with the opportunity to broaden the presence of the SwaddleMe® brand into high-end department stores and premium specialty retailers. In addition, in 2015 we plan to launch our WiFi 3.0 monitor and to expand on our success with the 3D lite convenience Stroller. We expect to continue to execute on our growth strategy in 2015 by continuing to offer innovative products and to build upon consumer recognition of the Summer®, SwaddleMe®, and Born Free® brands. Summary of Critical Accounting Policies and Estimates The following summary of our critical accounting policies is presented to assist in understanding our consolidated financial statements. The consolidated financial statements and notes are representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the consolidated financial statements. Additional information about our accounting policies and estimates may be found in Note 1 to our consolidated financial statements included in this report. We make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses. The accounting policies described below are those we consider critical in preparing our financial statements. Some of these policies include significant estimates made by management using information available at the time the estimates were made. However, these estimates could change materially if different information or assumptions were used. Revenue Recognition We record revenue when all of the following occur: persuasive evidence of an arrangement exists, product delivery has occurred, the sales price to the customer is fixed or determinable and collectability is reasonably assured. Sales are recorded net of provisions for returns and allowances, cash discounts and markdowns. We base our estimates for discounts, returns and allowances on negotiated customer terms, and historical experience. These estimates are subject to variability, as actual deductions taken by customers may be different from the estimates recorded. Customers do not have the right to return products unless the products are defective. We record a reduction of sales for estimated future defective product deductions based on contractual terms and historical experience. Sales incentives or other consideration given by us to customers that are considered adjustments of the selling price of products, such as markdowns, are reflected as reductions of revenue. Sales incentives and other consideration that represent costs incurred by us for assets or services received, such as the appearance of our products in a customer's national circular ad (co-op advertising), are reflected as selling and marketing expenses in our accompanying statements of income. Trade Receivables Trade receivables are reported at their outstanding unpaid principal balances reduced by an allowance for doubtful accounts. On a periodic basis, we estimate doubtful accounts based on historical bad debt, factors related to specific customers' ability to pay and current economic trends. We write off accounts receivable against the allowance when a balance is determined to be uncollectible. Amounts 16 Table of Contents are considered to be uncollectable based upon historical experience and management's evaluation of outstanding accounts receivable. We do not accrue interest on trade receivables. A receivable is considered past due if payments have not been received within the credit terms on the account, typically 30-60 days for most customers. We will turn an account over for collection when approximately 120 days past due. Accounts are considered uncollectible if no payments are received 60 to 90 days after they have been turned over for collection. Allowance for Doubtful Accounts The allowance for doubtful accounts represents adjustments to customer trade accounts receivable for amounts deemed uncollectible. The allowance for doubtful accounts reduces gross trade receivables to their estimated net realizable value. The allowance is based on our assessment of the business environment, customers' financial condition, historical trends, customer payment practices, receivable aging and customer disputes. We will continue to proactively review our credit risks and adjust customer terms to reflect the current environment. Inventory Valuation Inventory is comprised of finished goods and is stated at the lower of cost, inclusive of freight and duty, or market (net realizable value) using the first-in, first-out (FIFO) method. Our warehousing costs are charged to expense as incurred. We regularly review slow-moving and excess inventory, and write-down inventories as appropriate. Management uses estimates to record write-downs based on its review of inventory by product category, including length of time on hand and estimates of future orders for each product. Changes in consumer preferences, as well as demand for products, customer buying patterns and inventory management could impact the inventory valuation. Long-Lived Assets with Finite Lives We review long-lived assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered to be impaired when its carrying amount exceeds both the sum of the undiscounted future net cash flows expected to result from the use of the asset and its eventual disposition and the assets' fair value. Long-lived assets include property and equipment and finite-lived intangible assets. The amount of impairment loss, if any, is charged by us to current operations. Indefinite-Lived Intangible Assets We account for indefinite-lived intangible assets in accordance with accounting guidance that requires indefinite-lived intangible assets be tested annually for impairment and more frequently if events or changes in circumstances indicate that the asset might be impaired. Our annual impairment testing is conducted in the fourth quarter of every year. We test indefinite-lived intangible assets for impairment by comparing the asset's fair value to its carrying amount. If the fair value is less than the carrying amount, the excess of the carrying amount over fair value is recognized as an impairment charge and the adjusted carrying amount becomes the assets' new accounting basis. Management also evaluates the remaining useful life of an intangible asset that is not being amortized each reporting period to determine whether events and circumstances continue to support an indefinite useful life. If an intangible asset that is not being amortized is subsequently determined to have a finite useful life, it is amortized prospectively over its estimated remaining useful life. 17 Table of Contents Income Taxes Income taxes are computed using the asset and liability method of accounting. Under the asset and liability method, a deferred tax asset or liability is recognized for estimated future tax effects attributable to temporary differences and carry forwards. The measurement of deferred income tax assets is adjusted by a valuation allowance, if necessary, to recognize future tax benefits only to the extent, based on available evidence; it is more likely than not that such benefit will be realized. We recognize interest and penalties, if any, related to uncertain tax positions in interest expense. No interest and penalties related to uncertain tax positions were accrued at January 3, 2015. All audit adjustments have been recorded without significant impact on our results of operations. On a global basis, the open tax years subject to examination by major taxing jurisdictions in which we operate is between two to six years. Results of Operations The following table presents selected condensed consolidated financial information for our Company for the years ended January 3, 2015 ("fiscal year 2014") and December 31, 2013 ("fiscal year 2013"). Fiscal Year 2014 Compared with Fiscal Year 2013 Net sales declined 1.4% from $208,173 for fiscal 2013 to $205,359 for fiscal year 2014. The decline was primarily attributable to our having exited licensing arrangements with Disney® and Carters® in 2013 and early 2014 to focus on building our own branded products of Summer®, SwaddleMe®, and Born Free® in fiscal 2014 and lower closeout sales in fiscal 2014. Excluding $16.9 million and $0.6 million of sales related to our exit of the Disney® and Carters® licensing arrangements in fiscal 2013 and 2014, respectively, 2014 net sales increased 5.3%. Gross profit increased 3.0% from $65,007 for fiscal year 2013 to $66,941 for fiscal year 2014, and gross margin increased from 31.2% for fiscal year 2013 to 32.6% for fiscal year 2014. The increase in gross profit and 140 basis point improvement in gross margin was due to a favorable mix of higher margin products sold, partially offset by the effect of the voluntary battery recall announced in the second quarter of fiscal year 2014 and inventory charges related to product categories to be phased out. Excluding $300 relating to the battery recall and $617 of nonrecurring inventory charges related to exiting our licensing arrangements in fiscal year 2014, gross margin was 33.0%. General and administrative expenses increased 5.9% from $38,022 for fiscal year 2013 to $40,273 for fiscal year 2014. General and administrative expenses also increased as a percent of sales from 18 Year ended January 3, 2015 Year Ended December 31, 2013 Net sales $ 205,359 100.0 % $ 208,173 100.0 % Cost of goods sold 138,418 67.4 % 143,166 68.8 % Gross profit 66,941 32.6 % 65,007 31.2 % General and administrative expenses 40,273 19.6 % 38,022 18.3 % Selling expenses 18,437 9.0 % 20,839 10.0 % Depreciation and amortization 5,548 2.7 % 6,280 3.0 % Income (loss) from operations 2,683 1.3 % (134 ) (0.0 )% Interest expense, net 3,455 1.7 % 3,999 1.9 % (Benefit) for income taxes (527 ) 0.3 % (1,318 ) 0.6 % Net loss $ (245 ) (0.1 )% $ (2,815 ) (1.4 )% ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Table of Contents 18.3% for fiscal year 2013 to 19.6% for fiscal year 2014. Excluding charges of $2,202 associated with leadership changes for fiscal year 2014, general and administrative expenses were $38,071 or 18.5%. Selling expenses decreased 11.5% from $20,839 for fiscal year 2013 to $18,437 for fiscal year 2014, and decreased as a percent of sales from 10.0% for fiscal year 2013 to 9.0% for fiscal year 2014. This decrease was primarily attributable to additional cost controls implemented over retailer programs such as cooperative advertising and lower royalty costs under licensing agreements as part of discontinuing certain licensing arrangements. Depreciation and amortization decreased 11.7% from $6,280 in fiscal year 2013 to $5,548 for fiscal year 2014. The decrease in depreciation and amortization is attributable to a reduction in capital investment partially offset by higher amortization on new finite-lived intangible assets capitalized in 2013. Interest expense decreased 13.6% from $3,999 in fiscal year 2013 to $3,455 for fiscal year 2014 as a result of lower average interest rates. For fiscal year 2013, we recorded a $1,318 benefit for income taxes on $4,133 pretax loss, reflecting an estimated 31.9% tax rate for the period. For fiscal year 2014, we recorded a $527 tax benefit on $772 of pretax loss for the period. Excluding the effect of $197 of reinstated research and development tax credits as a discrete items for the year, the adjusted tax rate for fiscal 2014 was 42.8%. Liquidity and Capital Resources We fund our operations and working capital needs through cash generated from operations and borrowings under our credit facilities. Cash Flows In our typical operational cash flow cycle, inventory is purchased to meet expected demand plus a safety stock. Because the majority of our suppliers are based in Asia, inventory takes approximately three to four weeks to arrive from Asia to the various distribution points we maintain in the United States, Canada and the United Kingdom. Payment terms for these vendors are approximately 60-90 days from the date the product ships from Asia, therefore we are generally paying for the product a short time after it is physically received in the United States. In turn, sales to customers generally have payment terms of 30 to 60 days, resulting in an accounts receivable and increasing the amount of cash required to fund working capital. To bridge the gap between paying our suppliers and receiving payment from our customers for goods sold, we rely on our credit facilities. The majority of our capital expenditures are for tools and molds related to new product introductions. We receive indications from retailers generally around the middle of each year as to what products the retailer will be taking into its product line for the upcoming year. Based on these indications, we will acquire tools and molds required to build and produce the products. In most cases, the payments for the tools and molds are spread over a three to four month period. For fiscal year 2014, net cash used in operating activities totaled $6,276. The use of cash in fiscal year 2014 is primarily attributable to investments made in inventory for 1) safety stock for improving sales, 2) new product introductions, and 3) in anticipation of a potential port strike on the West Coast of the United States, where our main distribution center is located, as well as an increase in receivables on higher year over year sales in the fourth quarter. We expect inventory to decline in fiscal 2015 as some of these needs subside. For fiscal year 2013, net cash provided by operating activities totaled $19,061. The cash generated in fiscal year 2013 is primarily attributable to the nonrepeating benefit generated from improved working capital management during the year. 19 Table of Contents For fiscal year 2014, net cash used in investing activities was approximately $2,960. For fiscal year 2013, net cash used in investing activities was $4,322. The decline in net cash used in investing activities was primarily attributable to improved capital investment management. For fiscal year 2014, net cash provided by financing activities was approximately $9,040, reflecting borrowings primarily to pay for investments made in working capital during the year. For fiscal year 2013, net cash used in financing activities was $15,787, reflecting a pay down of our credit facilities. Based primarily on the above factors, net cash decreased for fiscal year 2014 by $301, resulting in a cash balance of approximately $1,272 at fiscal year end. The following table summarizes our significant contractual commitments at fiscal 2014 year end: Estimated future interest payments on our line of credit were based upon the interest rates in effect at January 3, 2015. Capital Resources In addition to operating cash flow, we also rely on our existing asset-based revolving credit facility with Bank of America, N.A. to meet our financing requirements, which are subject to changes in our inventory and account receivable levels. We regularly evaluate market conditions, our liquidity profile, and various financing alternatives for opportunities to enhance our capital structure. If market conditions are favorable, we may refinance our existing debt or issue additional securities. Based on past performance and current expectations, we believe that our anticipated cash flow from operations and availability under our existing credit facility are sufficient to fund our working capital, capital expenditures and debt service requirements for at least the next 12 months. However, if we are unable to meet our current financial forecast and cannot raise additional funds or adjust our operations accordingly, we may not remain in compliance with the financial covenants required under our revolving credit facility. Unforeseen circumstances, such as softness in the retail industry or deterioration in the business of a significant customer, could create a situation where we cannot access all of our available lines of credit due to not having sufficient assets or fixed charge coverage ratio as required under our credit facility. There is no assurance that we will meet all of our financial or other covenants in the future, or that our lenders will grant waivers if there are covenant violations. In addition, should we need to raise additional funds through additional debt or equity financings, any sale of additional debt or equity securities may cause dilution to existing stockholders. If sufficient funds are not available or are not available on acceptable terms, our ability to address any unexpected changes in our operations could be limited. Furthermore, there can be no assurance that we will be able to raise such funds if and when they are required. Failure to obtain future funding when needed or on acceptable terms could materially adversely affect our results of operations. 20 Payment Due by Period Contractual Obligations Total 2015 2016 2017 2018 and beyond BofA Agreement $ 45,778 — — — $ 45,778 Term Loan 12,750 $ 1,500 $ 1,500 $ 1,500 8,250 Estimated future interest payments on BofA Agreement 4,417 1,060 1,060 1,060 1,237 Estimated future interest payments on Term Loan 3,643 1,294 1,181 1,013 155 Operating leases 3,799 1,936 1,363 339 161 Capital leases and other liabilities 706 537 169 — — Total contractual cash obligations $ 71,093 $ 6,327 $ 5,273 $ 3,912 $ 55,581 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Table of Contents Credit Facility The following is a summary of our existing credit facility. Additional information about the credit facility may be found in Note 4 to our consolidated financial statements included in this report. On February 28, 2013, we, along with our subsidiary, Summer Infant (USA), Inc., entered into a new loan and security agreement with Bank of America, N.A. to provide an $80,000, asset-based revolving credit facility (as subsequently amended, the "BofA Agreement"). The BofA Agreement replaced our prior credit facility with Bank of America, which was set to expire in December 2013. In conjunction with our entry into the BofA Agreement, we also entered into a term loan agreement with Salus Capital Partners, which is described below under the heading "Term Loan." The BofA Agreement provides for an $80,000, asset-based revolving credit facility, with a $10,000 letter of credit sub-line facility. The total borrowing capacity is based on a borrowing base, which is defined as 85% of our eligible accounts receivable plus the lesser of (i) 70% of the value of eligible inventory or (ii) 85% of the net orderly liquidation value of eligible inventory, less reserves. The scheduled maturity date of loans under the BofA Agreement is February 28, 2018, subject to customary early termination provisions. All obligations under the BofA Agreement are secured by substantially all of our assets, subject to a first priority lien on certain assets held by the Term Loan lender described below. In addition, Summer Infant Canada Limited and Summer Infant Europe Limited, our subsidiaries, are guarantors under the BofA Agreement. Proceeds from the loans under the BofA Agreement were used to satisfy existing debt, pay fees and transaction expenses associated with the closing of the BofA Agreement, pay obligations under the prior BofA Agreement, and were used to make payments on the Term Loan and for other general corporate purposes, including working capital. Loans under the BofA Agreement bear interest, at our option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability under the BofA Agreement and ranging between 1.75% and 2.25% on LIBOR borrowings and 0.25% and 0.75% on base rate borrowings. Interest payments are due monthly, payable in arrears. We are also required to pay an annual non-use fee of 0.375% of the unused amounts under the BofA Agreement, as well as other customary fees as are set forth in the BofA Agreement. As of January 3, 2015, the base rate on loans was 4.0% and the LIBOR rate was 2.5%. Under the BofA Agreement, we are required to comply with certain financial covenants. We are required to maintain a trailing twelve month fixed charge coverage ratio of at least 1.0 to 1.0, tested on a monthly basis. The BofA Agreement contains customary affirmative and negative covenants. Among other restrictions, we are restricted in our ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless, in each case, certain conditions are satisfied. The BofA Agreement also contains customary events of default, including a cross default with the Term Loan, the occurrence of a material adverse event and the occurrence of a change of control. In the event of a default, all of our obligations and the obligations of our subsidiaries under the BofA Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations would become due and payable. The amount outstanding on the BofA Agreement at January 3, 2015 was $45,777. Total borrowing capacity under the BofA Agreement at January 3, 2015 was $54,577 and borrowing availability was $8,800. We were in compliance with the financial covenants under the BofA Agreement as of January 3, 2015. Term Loan On February 28, 2013, we, along with our subsidiary, Summer Infant (USA), Inc., as borrowers, entered into a term loan agreement (as subsequently amended, the "Term Loan Agreement") with Salus Capital Partners, LLC for a $15,000 term-loan (as subsequently amended, the "Term Loan"). 21 Table of Contents Proceeds from the Term Loan were used to repay certain existing debt, and to finance the acquisition of working capital assets in the ordinary course of business, capital expenditures, and for other general corporate purposes. The Term Loan is secured by certain of our assets, including a first priority lien on intellectual property, plant, property and equipment, and a pledge of 65% of the ownership interests in certain of our subsidiaries. The Term Loan matures on February 28, 2018. In addition, Summer Infant Canada Limited and Summer Infant Europe Limited, our subsidiaries, are guarantors under the Term Loan Agreement. The principal of the Term Loan is being repaid, on a quarterly basis, in installments of $375, commencing with the quarter ending September 30, 2013, until paid in full on termination. The Term Loan bears interest at an annual rate equal to LIBOR, plus 10%, with a LIBOR floor of 1.25%. Interest payments are due monthly, in arrears. As of January 3, 2015, the interest rate on the Term Loan was 11.25%. The Term Loan Agreement contains customary affirmative and negative covenants substantially the same as the BofA Agreement described above. In addition, we are required to maintain a trailing twelve month senior leverage ratio of 1:1, tested on a monthly basis of no more than 5.0 to 1.0.The Term Loan Agreement also contains events of default, including a cross default with the BofA Agreement, the occurrence of a material adverse event, the occurrence of a change of control, and the recall of products having a value of $2,000 or more. In the event of a default, all of our obligations and the obligations of our subsidiaries under the Term Loan Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations would become due and payable. The amount outstanding on the Term Loan at January 3, 2015 was $12,750. We were in compliance with the financial covenants under the Term Loan Agreement as of January 3, 2015. Off-Balance Sheet Arrangements We did not have any off-balance sheet arrangements during the year ended January 3, 2015 or the year ended December 31, 2013. Recently Issued Accounting Pronouncements In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance will be effective beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are currently evaluating the impact of the adoption of this guidance on its consolidated financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements. Special Note Regarding Forward Looking Statements This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements concern management's current assumptions, estimates, beliefs, plans, strategies and expectations and anticipated events or trends and similar expressions concerning matters that are not historical facts. Such forward-looking information may be identified by terms such as 22 Table of Contents "expect," "anticipate," "believe," "outlook," "may," "estimate," "should," "predict" and similar terms or variations thereof, and includes statements regarding the effectiveness of our strategy to promote future growth and profitability, the strength of our customer and supplier relationships, our liquidity for the next 12 months, the ability of our new leadership team and expected trends and product offerings in 2015. These statements are based on a series of expectations, assumptions, estimates and projections about our Company, are not guarantees of future results or performance, and involve significant risks, uncertainties and other factors, including assumptions and projections, for all forward periods. Our actual results may differ materially from any future results expressed or implied by such forward-looking statements. Such factors include, among others, the following: • the concentration of our business with a small number of retail customers; • the purchasing policies of and advertising and promotional support from our customers; • our ability to compete by introducing new products or enhancing existing products that satisfy consumer preferences; • our ability to develop new products in a timely and cost-efficient manner; • our ability to manage inventory levels and meet customer demand; • our ability to comply with financial and other covenants in our debt agreements; • our reliance on foreign suppliers and potential disruption in foreign markets in which we operate; • increases in the cost of raw materials used to manufacture our products; • our ability to protect our intellectual property; • compliance with safety and testing regulations for our products; • product liability claims arising from use of our products; • our dependence on key personnel; • unanticipated tax liabilities; and • an impairment of other intangible assets. The foregoing list of important factors does not include all such factors, nor necessarily present them in order of importance. In addition, please refer to the "Risk Factors" section of this report for additional information regarding factors that could affect our results of operations, financial condition and liquidity. We intend our forward-looking statements to speak only as of the time of such statements and do not undertake or plan to update or revise them as more information becomes available or to reflect changes in expectations, assumptions or results. We cannot give any assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of, or any material adverse change in, one or more of the risk factors or risks and uncertainties referred to in this report or included in our other periodic reports filed with the SEC could materially and adversely impact our operations and our future financial results. Any public statements or disclosures by us following this report that modify or impact any of the forward-looking statements contained in or accompanying this report will be deemed to modify or supersede such outlook or other forward-looking statements in or accompanying this report. Item 7A. Quantitative and Qualitative Disclosures About Market Risk Not required. 23 Table of Contents Item 8. Financial Statements and Supplementary Data The financial statements required by this item are attached to this Annual Report on Form 10-K beginning on Page F-1. Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure None. Item 9A. Controls and Procedures (a) Evaluation of Disclosure Controls and Procedures As required by Rule 13a-15 under the Securities Exchange Act of 1934, as of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of January 3, 2015. Our principal executive officer and principal financial officer have concluded, based on their evaluation, that our disclosure controls and procedures were effective as of January 3, 2015. (b) Management's Report on Internal Control over Financial Reporting Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting. As defined in Rule 13a-15(f) under the Exchange Act, internal control over financial reporting is a process designed by, or under the supervision of, a company's principal executive and principal financial officers and effected by a company's board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. It includes those policies and procedures that: 1) Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of a company; 2) Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of a company are being made only in accordance with authorizations of management and the board of directors of the company; and 3) Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or deposition of a company's assets that could have a material effect on its financial statements. Because of the inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The Company's management has used the criteria established in the 1992 "Internal Control—Integrated Framework" issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO Framework") to evaluate the effectiveness of the Company's internal control over financial reporting. Management has selected the 1992 COSO Framework for its evaluation as it is a control framework recognized by the SEC and the Public Company Accounting Oversight Board, that is free from bias, permits reasonably consistent qualitative and quantitative measurement of the Company's internal controls, is sufficiently complete so that relevant controls are not omitted, and is relevant to an evaluation of internal controls over financial reporting. 24 Table of Contents Management of the Company conducted an evaluation of the effectiveness, as of January 3, 2015, of the Company's internal control over financial reporting and based on its evaluation under the COSO Framework, management has concluded that the Company's internal control over financial reporting was effective as of January 3, 2015. (c) Changes in Internal Control Over Financial Reporting There was no change in our internal control over financial reporting that occurred during the quarter ended January 3, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. Item 9B. Other Information Not applicable. 25 Table of Contents PART III Item 10. Directors, Executive Officers and Corporate Governance The information relating to directors and director nominees of the Company is set forth in our definitive Proxy Statement to be filed with the SEC in connection with our 2015 Annual Meeting of Stockholders (the "2015 Proxy Statement") and is incorporated herein by reference. The information relating to the Company's executive officers and Section 16(a) beneficial ownership reporting compliance is set forth in the 2015 Proxy Statement and is also incorporated herein by reference. We have adopted a Code of Ethics that applies to all of our directors, officers and employees. The Code of Ethics is publicly available in the Investor Relations section of our website at www.summerinfant.com. Amendments to the Code of Ethics and any grant of a waiver from a provision of the Code of Ethics requiring disclosure under applicable SEC and Nasdaq rules will be disclosed on our website. The information relating to the Company's Audit Committee and its designated audit committee financial expert is set forth in the 2015 Proxy Statement and is incorporated herein by reference. The information concerning procedures by which stockholders may recommend director nominees is set forth in the 2015 Proxy Statement and is incorporated herein by reference. Item 11. Executive Compensation The information relating to executive compensation is set forth in the 2015 Proxy Statement and is incorporated herein by reference, provided that the information under the caption "Compensation Committee Report" shall be deemed "furnished" and shall not be deemed "filed" with this report, not deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except only as may be expressly set forth in any such filing by specific reference. Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters The information relating to security ownership of management, certain beneficial owners, and the Company's equity plans is set forth in the 2015 Proxy Statement and is incorporated herein by reference. Item 13. Certain Relationships and Related Transactions, and Director Independence The information relating to certain relationships and related party transactions and director independence is set forth in the 2015 Proxy Statement and is incorporated herein by reference. Item 14. Principal Accounting Fees and Services The information relating to the independent registered public accounting firm fees and services and the Company's pre-approval policies and procedures for audit and non-audit services provided by such accounting firm is set forth in the 2015 Proxy Statement and is incorporated herein by reference. 26 Table of Contents PART IV Item 15. Exhibits and Financial Statement Schedules (a) (1) Financial Statements The list of consolidated financial statements and notes required by this Item 15 (a)(1) is set forth in the "Index to Financial Statements" on page F-1 of this Annual Report. (2) Financial Statement Schedules All schedules have been omitted because the required information is included in the financial statements or notes thereto. (b) Exhibits The exhibits listed in the "Index to Exhibits" immediately preceding the exhibits are filed as part of this Annual Report. 27 Table of Contents SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 4th day of March 2015. Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. 28 SUMMER INFANT, INC. By: /s/ CAROL E. BRAMSON Carol E. Bramson Chief Executive Officer (Principal Executive Officer) By: /s/ WILLIAM E. MOTE, JR. William E. Mote, Jr. Chief Financial Officer (Principal Financial and Accounting Officer) Name Title Date /s/ CAROL E. BRAMSON Carol E. Bramson Chief Executive Officer and Director (Principal Executive Officer) March 4, 2015 /s/ WILLIAM E. MOTE, JR. William E. Mote, Jr. Chief Financial Officer (Principal Financial and Accounting Officer) March 4, 2015 /s/ DAN ALMAGOR Dan Almagor Director March 4, 2015 /s/ MARTIN FOGELMAN Martin Fogelman Director March 4, 2015 /s/ JASON MACARI Jason Macari Director March 4, 2015 /s/ DERIAL SANDERS Derial Sanders Director March 4, 2015 Table of Contents 29 Name Title Date /s/ ROBERT STEBENNE Robert Stebenne Director March 4, 2015 /s/ RICHARD WENZ Richard Wenz Director March 4, 2015 /s/ STEPHEN ZELKOWICZ Stephen Zelkowicz Director March 4, 2015 Table of Contents Summer Infant, Inc. and Subsidiaries Index to Financial Statements F-1 Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets F-3 Consolidated Statements of Operations F-4 Consolidated Statements of Comprehensive Loss F-5 Consolidated Statements of Cash Flows F-6 Consolidated Statements of Stockholders' Equity F-7 Notes to Consolidated Financial Statements F-8 - F-24 Table of Contents REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders Summer Infant, Inc. We have audited the accompanying consolidated balance sheets of Summer Infant, Inc. and Subsidiaries as of January 3, 2015 and December 31, 2013, and the related consolidated statements of operations, comprehensive loss, cash flows, and stockholders' equity for the years then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's controls over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Summer Infant, Inc. and Subsidiaries as of January 3, 2015 and December 31, 2013, and the results of their operations and their cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles. /s/ McGladrey LLP McGladrey LLP Boston, Massachusetts March 4, 2015 F-2 Table of Contents Summer Infant, Inc. and Subsidiaries Consolidated Balance Sheets Note that all amounts presented in the table below are in thousands of U.S. dollars, except share amounts and par value per share. See notes to consolidated financial statements. F-3 January 3, 2015 December 31, 2013 ASSETS CURRENT ASSETS Cash and cash equivalents $ 1,272 $ 1,573 Trade receivables, net of allowance for doubtful accounts of $159 and $100 at January 3, 2015 and December 31, 2013, respectively 38,794 34,574 Inventory, net 44,010 38,378 Prepaids and other current assets 2,076 1,890 Deferred tax assets 1,194 832 TOTAL CURRENT ASSETS 87,346 77,247 Property and equipment, net 13,080 14,796 Other intangible assets, net 20,679 21,575 Other assets 1,362 1,749 TOTAL ASSETS $ 122,467 $ 115,367 ​ ​ ​ ​ ​ ​ LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable $ 21,878 $ 22,072 Accrued expenses $ 8,628 $ 9,658 Current portion of long-term debt and capital leases 1,641 1,962 TOTAL CURRENT LIABILITIES 32,147 33,692 Long-term debt, less current portion 57,097 47,756 Other liabilities 2,994 3,289 Deferred tax liabilities 2,378 3,140 TOTAL LIABILITIES 94,616 87,877 STOCKHOLDERS' EQUITY Preferred Stock, $0.0001 par value, 1,000,000 authorized, none issued or outstanding at January 3, 2015 and December 31, 2013 — — Common Stock $0.0001 par value, authorized, issued and outstanding of 49,000,000, 18,415,934, and 18,144,285 at January 3, 2015 and 49,000,000, 18,257,924 and 17,986,275 at December 31, 2013, respectively 2 2 Treasury Stock at cost (271,649 shares at January 3, 2015 and December 31, 2013) (1,283 ) (1,283 ) Additional paid-in capital 74,954 73,715 Accumulated deficit (44,412 ) (44,167 ) Accumulated other comprehensive loss (1,410 ) (777 ) TOTAL STOCKHOLDERS' EQUITY 27,851 27,490 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 122,467 $ 115,367 ​ ​ ​ ​ ​ ​ Table of Contents Summer Infant, Inc. and Subsidiaries Consolidated Statements of Operations Note that all amounts presented in the table below are in thousands of U.S. dollars, except share and per share amounts. See notes to consolidated financial statements. F-4 For the fiscal year ended January 3, 2015 December 31, 2013 Net sales $ 205,359 $ 208,173 Cost of goods sold 138,418 143,166 Gross profit 66,941 65,007 General and administrative expenses 40,273 38,022 Selling expenses 18,437 20,839 Depreciation and amortization 5,548 6,280 Operating income (loss) 2,683 (134 ) Interest expense, net 3,455 3,999 Loss before provision for income taxes (772 ) (4,133 ) (Benefit) for income taxes (527 ) (1,318 ) NET LOSS $ (245 ) $ (2,815 ) ​ ​ ​ ​ ​ ​ Net loss per share BASIC $ (0.01 ) $ (0.16 ) Weighted average shares outstanding BASIC 18,060,799 17,929,734 Net loss per share DILUTED $ (0.01 ) $ (0.16 ) Weighted average shares outstanding DILUTED 18,060,799 17,929,734 Table of Contents Summer Infant, Inc. and Subsidiaries Consolidated Statements of Comprehensive Loss Note that all amounts presented in the table below are in thousands of U.S. dollars. See notes to consolidated financial statements. F-5 For the fiscal year ended January 3, 2015 December, 31 2013 Net loss $ (245 ) $ (2,815 ) Other comprehensive loss: Cumulative changes in foreign currency translation adjustments $ (633 ) (573 ) Comprehensive loss $ (878 ) $ (3,388 ) ​ ​ ​ ​ ​ ​ Table of Contents Summer Infant, Inc. and Subsidiaries Consolidated Statements of Cash Flows Note that all amounts presented in the table below are in thousands of U.S. dollars. See notes to consolidated financial statements. F-6 For the fiscal year ended January 3, 2015 December 31, 2013 Cash flows from operating activities: Net loss $ (245 ) $ (2,815 ) Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation and amortization 5,548 6,280 Stock-based compensation 1,220 893 Loss on asset disposal — 70 Deferred income taxes (1,130 ) (715 ) Changes in assets and liabilities, net of effects of acquisitions (Increase) decrease in accounts receivable (4,622 ) 10,682 (Increase) decrease in inventory (6,093 ) 11,426 (Increase) decrease in prepaids and other current assets (86 ) 604 Decrease (increase) in other assets 392 (1,744 ) (Decrease) in accounts payable and accrued expenses (1,260 ) (5,620 ) Net cash (used in) provided by operating activities (6,276 ) 19,061 Cash flows from investing activities: Acquisitions of property and equipment (2,733 ) (3,259 ) Acquisitions of other intangible assets (227 ) (1,114 ) Proceeds from sale of assets — 138 Acquisitions, net of cash acquired — (87 ) Net cash used in investing activities (2,960 ) (4,322 ) Cash flows from financing activities: Net borrowings (repayments) of debt 9,021 (15,819 ) Issuance of common stock upon exercise of stock options 19 32 Net cash provided by (used in) financing activities 9,040 (15,787 ) Effect of exchange rate changes on cash and cash equivalents (105 ) (511 ) Net decrease in cash and cash equivalents (301 ) (1,559 ) Cash and cash equivalents at beginning of year 1,573 3,132 Cash and cash equivalents at end of year $ 1,272 $ 1,573 ​ ​ ​ ​ ​ ​ Supplemental disclosure of cash flow information: Cash paid during the year for interest $ 3,310 $ 3,428 Cash paid during the year for income taxes $ 90 $ 96 Table of Contents Consolidated Statements of Stockholders' Equity For the Fiscal Years Ended January 3, 2015 and December 31, 2013 Note that all amounts presented in the table below are in thousands of U.S. dollars, except per share data. See notes to consolidated financial statements. F-7 Common Stock Additional Paid in Capital Treasury Stock Retained Earnings Accumulated Comprehensive Income (Loss) Total Equity Shares Amount Balance at December 31, 2012 17,862,296 $ 2 $ 72,790 $ (1,283 ) $ (41,352 ) $ (204 ) $ 29,953 Issuance of common stock upon vesting of restricted shares 111,479 Issuance of common stock upon exercise of stock options 12,500 — 32 32 Stock-based compensation 893 893 Net loss for the year (2,815 ) (2,815 ) Foreign currency translation adjustment (573 ) (573 ) Balance at December 31, 2013 17,986,275 $ 2 $ 73,715 $ (1,283 ) $ (44,167 ) $ (777 ) $ 27,490 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Issuance of common stock upon vesting of restricted shares 152,010 Issuance of common stock upon exercise of stock options 6,000 — 19 19 Stock-based compensation 1,220 1,220 Net loss for the year (245 ) (245 ) Foreign currency translation adjustment (633 ) (633 ) Balance at January 3, 2015 18,144,285 $ 2 $ 74,954 $ (1,283 ) $ (44,412 ) $ (1,410 ) $ 27,851 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations The Company designs, markets and distributes branded juvenile health, safety and wellness products that are sold globally to large national retailers as well as independent retailers, primarily in North America. The Company currently markets its products in several product categories including monitoring, safety, nursery, baby gear, and feeding products. Most products are sold under our core brand names of Summer®, SwaddleMe®, and Born Free®. Basis of Presentation and Principles of Consolidation It is the Company's policy to prepare its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America. The consolidated financial statements include the accounts of its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the consolidation. All dollar amounts included in the Notes to Consolidated Financial Statements are in thousands of U.S. dollars except share and per share amounts. Change in Fiscal Year In December 2014, the Board of Directors approved a change in the Company's fiscal year, from a fiscal year ending on December 31 of each calendar year to a fiscal year ending on the Saturday closest to December 31 of each calendar year. This change is effective with the current fiscal year such that the Company's fiscal year ended on January 3, 2015. Summary of Significant Accounting Policies Revenue Recognition The Company records revenue when all of the following occur: persuasive evidence of an arrangement exists, product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. Sales are recorded net of provisions for returns and allowances, customer discounts, and other sales related discounts. The Company bases its estimates for discounts, returns and allowances on negotiated customer terms and historical experience. Customers do not have the right to return products unless the products are defective. The Company records a reduction of sales for estimated future defective product deductions based on contractual terms and historical experience. Sales incentives or other consideration given by the Company to customers that are considered adjustments of the selling price of products, such as markdowns, are reflected as reductions of revenue. Sales incentives and other consideration that represent costs incurred by the Company for assets or services received, such as the appearance of the Company's products in a customer's national circular ad, are reflected as selling and marketing expenses in the accompanying statements of operations. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts and disclosures. These estimates are based on management's best knowledge F-8 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) of current events and actions the Company may undertake in the future. Accordingly, actual results could differ from those estimates. Cash and Cash Equivalents Cash flows, cash and cash equivalents include money market accounts and investments with an original maturity of three months or less. At times, the Company possesses cash balances in excess of federally-insured limits. Trade Receivables Trade receivables are carried at their outstanding unpaid principal balances reduced by an allowance for doubtful accounts. The Company estimates doubtful accounts based on historical bad debts, factors related to specific customers' ability to pay and current economic trends. The Company writes off accounts receivable against the allowance when a balance is determined to be uncollectible. Amounts are considered to be uncollectable based upon historical experience and management's evaluation of outstanding accounts receivable. Inventory Valuation Inventory is comprised mostly of finished goods and some component parts and is stated at the lower of cost using the first-in, first-out (FIFO) method, or market (net realizable value). The Company regularly reviews slow-moving and excess inventories, and writes down inventories to net realizable value if the ultimate expected net proceeds from the disposals of excess inventory are less than the carrying cost of the merchandise. Property and Equipment Property and equipment are recorded at cost. The Company owns the tools and molds used in the production of its products by third party manufacturers. Capitalized mold costs include costs incurred for the pre-production design and development of the molds. Depreciation is provided over the estimated useful lives of the respective assets using either straight-line or accelerated methods. Long-Lived Assets with Finite Lives The Company reviews long-lived assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered to be impaired when its carrying amount exceeds both the sum of the undiscounted future net cash flows expected to result from the use of the asset and its eventual disposition and the assets' fair value. Long-lived assets include property and equipment and finite-lived intangible assets. The amount of impairment loss, if any, is charged by the Company to current operations. For each of the years ended January 3, 2015 and December 31, 2013, no such impairment existed. Indefinite-Lived Intangible Assets The Company accounts for intangible assets in accordance with accounting guidance that requires that intangible assets with indefinite useful lives be tested annually for impairment and more frequently F-9 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) if events or changes in circumstances indicate that the asset might be impaired. The Company's annual impairment testing is conducted in the fourth quarter of every year. The Company tests indefinite-lived intangible assets for impairment by comparing the asset's fair value to its carrying amount. If the fair value is less than the carrying amount, the excess of the carrying amount over fair value is recognized as an impairment charge and the adjusted carrying amount becomes the assets' new accounting basis. Management also evaluates the remaining useful life of an intangible asset that is not being amortized each reporting period to determine whether events and circumstances continue to support an indefinite useful life. If an intangible asset that is not being amortized is subsequently determined to have a finite useful life, it is amortized prospectively over its estimated remaining useful life. The Company determined that no impairment existed on its indefinite-lived intangible assets for the years ended January 3, 2015 and December 31, 2013. Fair Value Measurements The Company follows ASC 820, "Fair Value Measurements and Disclosures" which includes a framework for measuring fair value and expanded related disclosures. Broadly, the framework requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The standard established a three-level valuation hierarchy based upon observable and non-observable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy: Level 1—Quoted prices for identical instruments in active markets. Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3—Significant inputs to the valuation model are unobservable. The Company maintains policies and procedures to value instruments using the best and most relevant data available. In addition, the Company utilizes risk management resources that review valuation, including independent price validation. The Company's financial instruments include cash and cash equivalents, accounts and notes receivable, accounts payable, accrued expenses, and short and long-term borrowings. Because of their short maturity, the carrying amounts of cash and cash equivalents, accounts and notes receivable, accounts payable, accrued expenses and short-term borrowings approximate fair value. The carrying value of long-term borrowings approximates fair value, which is based on quoted market prices or on rates available to the Company for debt with similar terms and maturities. F-10 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) Income taxes Income taxes are computed using the asset and liability method of accounting. Under the asset and liability method, a deferred tax asset or liability is recognized for estimated future tax effects attributable to temporary differences and carryforwards. The measurement of deferred income tax assets is adjusted by a valuation allowance, if necessary, to recognize future tax benefits only to the extent, based on available evidence, it is more likely than not that such benefits will be realized. The Company follows the appropriate guidance relative to uncertain tax positions. This standard provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Uncertain tax positions must meet a recognition threshold of more-likely-than-not in order for those tax positions to be recognized in the financial statements. For years ended January 3, 2015 and December 31, 2013 the Company had no material uncertain tax positions or unrecognized tax benefits. The Company's federal tax return for the year ended December 31, 2009 was audited in 2012 by the Internal Revenue Service and all taxes and interest have been paid. Any tax penalties or interest is recorded as a general and administrative cost in operations. The Company expects no material changes to unrecognized tax positions within the next twelve months. Translation of Foreign Currencies The assets and liabilities of the Company's European, Canadian, Israeli, and Asian operations have been translated into U.S. dollars at year-end exchange rates and the income and expense accounts of these affiliates have been translated at average rates prevailing during each respective year. Resulting translation adjustments are made to a separate component of stockholders' equity within accumulated other comprehensive loss. Foreign exchange transaction gains and losses are included in the accompanying statements of operations and deemed immaterial. Shipping Costs Shipping costs to customers are included in selling expenses and amounted to approximately $1,889 and $1,521 for the years ended January 3, 2015 and December 31, 2013, respectively. Advertising Costs The Company charges advertising costs to selling, general and administration expense as incurred. Advertising expense, which consists primarily of promotional and cooperative advertising allowances provided to customers, was approximately $15,245 and $16,791 for the years ended January 3, 2015 and December 31, 2013, respectively. Net Loss Per Share Basic earnings per share is calculated by dividing net loss for the period by the weighted average number of common stock outstanding during the period. Diluted loss per share for the Company is computed by dividing net loss by the dilutive weighted average shares outstanding which includes: the dilutive impact (using the "treasury stock" method) of "in the money" stock options and unvested restricted shares issued to employees. Options to purchase F-11 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) 1,729,365 and 1,409,412 shares of the Company's common stock and 242,249 and 268,361 of restricted shares were not included in the calculation, due to the fact that these instruments were anti-dilutive for the years ended January 3, 2015 and December 31, 2013, respectively. New Accounting Pronouncements In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance will be effective beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements. 2. PROPERTY AND EQUIPMENT Property and equipment, at cost, consisted of the following: Property and equipment included amounts acquired under capital leases of approximately $1,387 and $3,010 at January 3, 2015 and December 31, 2013, respectively, with related accumulated depreciation of approximately $537 and $756, respectively. Total depreciation expense was $4,425 and $5,145 for the fiscal years ended January 3, 2015 and December 31, 2013, respectively. F-12 For the fiscal year ended January 3, 2015 December 31, 2013 Depreciation/ Amortization Period Computer-related $ 6,201 $ 5,672 5 years Tools, dies prototypes, and molds 28,667 26,372 1 - 5 years Building 4,156 4,156 30 years Other 5,437 5,584 various 44,461 41,784 Less: accumulated depreciation 31,381 26,988 Property and equipment, net $ 13,080 $ 14,796 ​ ​ ​ ​ ​ ​ ​ Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 3. INTANGIBLE ASSETS Intangible assets Intangible assets consisted of the following: The amortization period for the majority of the intangible assets ranges from 5 to 20 years for those assets that have an estimated life; certain assets have indefinite lives (brand names). Total of intangibles not subject to amortization amounted to $12,308 for the fiscal years ended January 3, 2015 and December 31, 2013, respectively. Amortization expense amounted to $1,123 and $1,135 for the fiscal years ended January 3, 2015 and December 31, 2013, respectively. Estimated amortization expense for the next five years is as follows: 4. DEBT Credit Facilities On February 28, 2013, the Company, along with its subsidiary, Summer Infant (USA), Inc., entered into a new loan and security agreement with Bank of America, N.A. to provide an $80,000, asset-based revolving credit facility (as subsequently amended on November 8, 2013, the "BofA Agreement"). The BofA Agreement replaced the Company's prior credit facility with Bank of America, which was set to expire in December 2013. In conjunction with its entry into the BofA Agreement, the Company also entered into a term loan agreement with Salus Capital Partners, which is described below under "Term Loan." BofA Agreement The BofA Agreement provides for an $80,000, asset-based revolving credit facility, with a $10,000 letter of credit sub-line facility. The total borrowing capacity is based on a borrowing base, which is F-13 For the fiscal year ended January 3, 2015 December 31, 2013 Brand names $ 14,812 $ 14,812 Patents and licenses 3,605 3,378 Customer relationships 6,946 6,946 Other intangibles 1,882 1,882 27,245 27,018 Less: accumulated amortization (6,566 ) (5,443 ) Intangible assets, net $ 20,679 $ 21,575 ​ ​ ​ ​ ​ ​ Fiscal Year ending 2015 $ 1,079 2016 1,079 2017 1,079 2018 1,058 2019 1,050 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 4. DEBT (Continued) defined as 85% of the Company's eligible accounts receivable plus the lesser of (i) 70% of the value of eligible inventory or (ii) 85% of the net orderly liquidation value of eligible inventory, less reserves. The scheduled maturity date of loans under the BofA Agreement is February 28, 2018, subject to customary early termination provisions. All obligations under the BofA Agreement are secured by substantially all of the Company's assets, subject to a first priority lien on certain assets held by the lender of the Term Loan as described below. In addition, Summer Infant Canada Limited and Summer Infant Europe Limited, the Company's subsidiaries, are guarantors under the BofA Agreement. Proceeds from the loans under the BofA Agreement were used to satisfy existing debt, pay fees and transaction expenses associated with the closing of the BofA Agreement, pay obligations under the prior BofA Agreement, and were used to make payments on the Term Loan and for other general corporate purposes, including working capital. Loans under the BofA Agreement bear interest, at the Company's option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability under the BofA Agreement and ranging between 1.75% and 2.25% on LIBOR borrowings and 0.25% and 0.75% on base rate borrowings. Interest payments are due monthly, payable in arrears. The Company is also required to pay an annual non-use fee of 0.375% of the unused amounts under the BofA Agreement, as well as other customary fees as are set forth in the BofA Agreement. As of January 3, 2015, the base rate on loans was 4.0% and the LIBOR rate was 2.5%. Under the BofA Agreement, the Company is required to comply with certain financial covenants. Prior to the execution of an amendment to the BofA Agreement on November 8, 2013, the Company was required, (i) for the first year of the loan, to maintain and earn a specified minimum, monthly consolidated EBITDA amount, as defined, in the BofA Agreement ("Bank EBITDA"), with such specified amounts increasing over the first twelve months of the loan to a minimum consolidated Bank EBITDA of $12,000 at February 28, 2014, and (ii) beginning with the fiscal quarter ending March 31, 2014, was to maintain a fixed charge coverage ratio of at least 1.0 to 1.0 for each period of four fiscal quarters most recently ended. For purposes of the financial covenants, consolidated Bank EBITDA is defined as net income before interest, taxes, depreciation and amortization, plus certain customary expenses, fees and non-cash charges and minus certain customary non-cash items increasing net income. On November 8, 2013, the Company entered into an amendment to the BofA Agreement (the "BofA Amendment"). The BofA Amendment amended the financial covenants in the BofA Agreement to provide that (i) the Company was no longer required to comply with the prior minimum Bank EBITDA covenants for any period ending after September 30, 2013 and (ii) the Company must maintain a trailing twelve month fixed charge coverage ratio of at least 1.0 to 1.0, tested on a monthly basis, from and after September 30, 2013. On December 12, 2014, the BofA agreement was further amended to reflect the Company's change in fiscal year. The BofA Agreement contains customary affirmative and negative covenants. Among other restrictions, the Company is restricted in its ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions are satisfied. The BofA Agreement also contains customary events of default, including a cross default with the Term Loan, the occurrence of a material adverse event and the occurrence of a change of control. In the event of a default, all of the Company's obligations and the obligations of its subsidiaries under the F-14 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 4. DEBT (Continued) BofA Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations would become due and payable. The amount outstanding on the BofA Agreement at January 3, 2015 was $45,777. Total borrowing capacity under the BofA Agreement at January 3, 2015 was $54,577 and borrowing availability was $8,800. Term Loan On February 28, 2013, the Company, along with its subsidiary, Summer Infant (USA), Inc., as borrowers, entered into a term-loan agreement (as subsequently amended on November 8, 2013, the "Term Loan Agreement") with Salus Capital Partners, LLC for a $15,000 term-loan (as subsequently amended, the "Term Loan"). Proceeds from the Term Loan were used to repay certain existing debt, and to finance the acquisition of working capital assets in the ordinary course of business, capital expenditures, and for other general corporate purposes. The Term Loan is secured by certain of the Company's assets, including a first priority lien on intellectual property, plant, property and equipment, and a pledge of 65% of the ownership interests in certain of the Company's subsidiaries. The Term Loan matures on February 28, 2018. In addition, Summer Infant Canada Limited and Summer Infant Europe Limited, the Company's subsidiaries, are guarantors under the Term Loan Agreement. The principal of the Term Loan is being repaid, on a quarterly basis, in installments of $375, commencing with the quarter ending September 30, 2013, until paid in full on termination. The Term Loan bears interest at an annual rate equal to LIBOR, plus 10%, with a LIBOR floor of 1.25%. Interest payments are due monthly, in arrears. As of January 3, 2015, the interest rate on the Term Loan was 11.25%. The Term Loan Agreement contains customary affirmative and negative covenants substantially the same as the BofA Agreement described above. In addition, prior to the execution of an amendment to the Term Loan Agreement on November 8, 2013, the Company was required to comply with certain financial covenants, including that the Company (i) meet the same minimum, monthly consolidated Bank EBITDA as set forth in the BofA Agreement and (ii) initially maintain a monthly senior leverage ratio of 1:1. For periods after February 28, 2014, the senior leverage ratio will be based on an annual business plan to be approved by the Company's Board of Directors and will be tested monthly on a trailing twelve month basis. For purposes of the financial covenants in the Term Loan Agreement, the senior leverage ratio was defined as the ratio of (1) all amounts outstanding under the Term Loan Agreement and the BofA Agreement to (2) consolidated Bank EBITDA for the twelve-month period ending as of the last day of the most recently ended fiscal month. The Term Loan Agreement also contains events of default, including a cross default with the BofA Agreement, the occurrence of a material adverse event, the occurrence of a change of control, and the recall of products having a value of $2,000 or more. In the event of a default, all of the Company's obligations and the obligations of its subsidiaries under the Term Loan Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations would become due and payable. F-15 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 4. DEBT (Continued) On November 8, 2013, the Company entered into an amendment to the Term Loan Agreement (the "Term Loan Amendment"). The Term Loan Amendment amended the financial covenants in the Term Loan Agreement to provide that (i) the Company is no longer required to comply with the minimum Bank EBITDA covenants for any period ending after September 30, 2013, (ii) the Company must maintain a trailing twelve month fixed charge coverage ratio of at least 1.0 to1.0, tested on a monthly basis, from and after September 30, 2013, and (iii) commencing February 28, 2014, the Company maintain a trailing twelve month senior leverage ratio, tested on a monthly basis of (a) no more than 6.0 to 1.0 for the periods ending on or before June 30, 2014, (b) no more than 5.5 to 1.0 for periods ending July 1, 2014 through September 30, 2014, and (c) no more than 5.0 to 1.0 for periods following September 30, 2014. On December 31, 2014, the Term Loan agreement was further amended to reflect the Company's change in fiscal year. The amount outstanding on the Term Loan at January 3, 2015 was $12,750. Aggregate maturities of bank debt related to the BofA credit facility and Term Loan are as follows: Sale-Leaseback On March 24, 2009, Summer Infant (USA), Inc., the Company's wholly owned subsidiary ("Summer USA"), entered into a definitive agreement with Faith Realty II, LLC, a Rhode Island limited liability company ("Faith Realty") (the members of which are Jason Macari, the former Chief Executive Officer of the Company and current director, and his spouse), pursuant to which Faith Realty purchased the corporate headquarters of the Company located at 1275 Park East Drive, Woonsocket, Rhode Island (the "Headquarters"), for $4,052 and subsequently leased the Headquarters back to Summer USA for an annual rent of $390 during the initial seven year term of the lease, payable monthly and in advance. The lease will expire on the seventh anniversary of its commencement, or 2016, unless an option period is exercised by Summer USA. At the end of the initial term, Summer USA will have the opportunity to extend the lease for one additional period of five years. If Summer USA elects to extend the term of the lease for an additional five years, the annual rent for the first two years of the extension term shall be equal to $429 and for the final three years of the extension term shall be equal to $468. In addition, during the first six months of the last lease year of the initial term of the lease, Summer USA has the option to repurchase the Headquarters for $4,457 (110% of the initial sale price). With the majority of the proceeds of the sale of the Headquarters Summer USA paid off the construction loan relating to the Headquarters. Mr. Macari has given a personal guarantee to secure the Faith Realty debt on its mortgage; therefore, due to his continuing involvement in the building transaction and the Company's option to repurchase the building, the transaction has been recorded as a financing lease, with no gain recognition. At January 3, 2015, approximately $312 was F-16 Fiscal Year ending: 2015 $ 1,500 2016 $ 1,500 2017 $ 1,500 2018 $ 54,027 Total $ 58,527 ​ ​ ​ ​ Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 4. DEBT (Continued) included in accounts payable and accrued expenses, with the balance of approximately $2,994 included in other liabilities, in the accompanying consolidated balance sheet. This obligation is reduced each month (along with a charge to interest expense) as the rent payment is made to Faith Realty. On February 25, 2009, the Company's Board of Directors (with Mr. Macari abstaining from such action) approved the sale leaseback transaction. In connection therewith, the Board of Directors granted a potential waiver, to the extent necessary, if at all, of the conflict of interest provisions of the Company's Code of Ethics, effective upon execution of definitive agreements within the parameters approved by the Board. In connection with granting such potential waiver, the Board of Directors engaged independent counsel to review the sale leaseback transaction and an independent appraiser to ascertain (i) the value of the Headquarters and (ii) the market rent for the Headquarters. In reaching its conclusion that the sale leaseback transaction is fair to the Company, the Board of Directors considered a number of factors, including Summer USA's ability to repurchase the headquarters at 110% of the initial sale price at the end of the initial term. In addition, the Company's Audit Committee approved the sale leaseback transaction (as a related party transaction) and the potential waiver and recommended the matter to a vote of the entire Board of Directors (which approved the transaction). 5. INCOME TAXES The benefit for income taxes is summarized as follows: F-17 Fiscal 2014 Fiscal 2013 Current: Federal $ 205 $ (15 ) Foreign 401 (599 ) State and local 20 (3 ) Total current 626 (617 ) Deferred (primarily federal) (1,153 ) (701 ) Total benefit $ (527 ) $ (1,318 ) ​ ​ ​ ​ ​ ​ Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 5. INCOME TAXES (Continued) The tax effects of temporary differences that comprise the deferred tax liabilities and assets are as follows: The following reconciles the benefit for income taxes at the U.S. federal income tax statutory rate to the benefit in the consolidated financial statements: The Company had undistributed earnings from certain foreign subsidiaries (Summer Infant Asia, Summer Infant Australia, and Born Free Holdings, Ltd) of approximately $13,796 at January 3, 2015, and all of these earnings are considered to be permanently reinvested due to the Company's plans to reinvest such earnings for future expansion in certain foreign jurisdictions. Earnings and profits from Summer Infant Europe and Summer Infant Canada are not considered to be permanently reinvested due to the bank refinancing as discussed in Note 4—Debt. The cumulative effect in 2014 was $29 and will affect future years based on earnings. The amount of taxes attributable to the permanently reinvested undistributed earnings is not practicably determinable. F-18 January 3, 2015 December 31, 2013 Assets (Liabilities) Deferred tax asset—current: Accounts receivable $ 21 $ 13 Inventory and Unicap reserve 1,035 694 Foreign tax credit carry-forward and other 138 125 Net deferred tax asset—current 1,194 832 Deferred tax (liability) asset—non-current: Research and development credit, foreign tax credit and net operating loss carry-forward 4,193 3,953 Intangible assets and other (3,850 ) (4,008 ) Property, plant and equipment (1,143 ) (1,776 ) Total deferred tax liability (800 ) (1,831 ) Valuation allowance (1,578 ) (1,309 ) Net deferred tax liability non-current: (2,378 ) (3,140 ) Net deferred income tax liability $ (1,184 ) $ (2,308 ) ​ ​ ​ ​ ​ ​ Fiscal 2014 Fiscal 2013 Tax benefit at statutory rate $ (262 ) $ (1,405 ) State income taxes, net of U.S. federal income tax benefit (76 ) 232 Stock options 213 121 Valuation allowance of state R&D credits (23 ) 110 Foreign tax rate differential (249 ) (184 ) Tax credits (173 ) (150 ) Non-deductible expenses 25 16 Other 18 (58 ) Total benefit $ (527 ) $ (1,318 ) ​ ​ ​ ​ ​ ​ Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 5. INCOME TAXES (Continued) As of January 3, 2015, the Company has approximately $246 of federal and state net operating loss carry forwards (or "NOLs") to offset future federal taxable income. The federal NOL will begin to expire in 2028 and the state NOL will begin to expire in 2016. The Company also has approximately $1,386 and $251 of NOLs in Canada and Australia which can be carried forward indefinitely. Authoritative guidance requires a valuation allowance to reduce the deferred tax assets reported, if based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all evidence, including the Company's past earnings history and future earnings forecast, management has determined that a valuation allowance in the amount of $1,578 relating to certain state tax credits is necessary at January 3, 2015. Upon the adoption, and at January 3, 2015 and December 31, 2013, the Company did not have any material uncertain tax positions. No interest and penalties related to uncertain tax positions were accrued at January 3, 2015 and December 31, 2013. On a global basis, the open tax years subject to examination by major taxing jurisdictions in which the Company operates is between two to six years. The Company expects no material changes to unrecognized tax positions within the next twelve months. 6. SHARE BASED COMPENSATION The Company is authorized to issue up to 3,000,000 shares for equity awards under the Company's 2006 Performance Equity Plan ("2006 Plan") and 1,100,000 shares for equity awards under the Company's 2012 Incentive Compensation Plan (as amended, "2012 Plan"). The Company's stockholders approved an increase in the number of shares available under the 2012 Plan from 500,000 to 1,100,000 shares on August 13, 2014. Periodically, the company also provides equity awards outside of the plans. Under the 2006 Plan and 2012 Plan, awards may be granted to participants in the form of non-qualified stock options, incentive stock options, restricted stock, deferred stock, restricted stock units and other stock-based awards. Subject to the provisions of the Plans, awards may be granted to employees, officers, directors, advisors and consultants who are deemed to have rendered or are able to render significant services to the Company or its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the Company's success. The Company accounts for options under the fair value recognition standard. The application of this standard resulted in share-based compensation expense for the twelve months ended January 3, 2015 and December 31, 2013 of $1,220 and $893, respectively. Share based compensation expense is included in selling, general and administrative expenses. The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the table below. The Company uses the simplified method to estimate the expected term of the options, but used an estimate for grants of "plain vanilla" stock options based on a formula prescribed by the Securities and Exchange Commission. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Share-based compensation expense recognized in the consolidated financial statements in fiscal 2014 and 2013 is based on awards that are ultimately expected to vest. F-19 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 6. SHARE BASED COMPENSATION (Continued) The following table summarizes the weighted average assumptions used for options granted during the fiscal years ended January 3, 2015 and December 31, 2013. The weighted-average grant date fair value of options granted during the year ended January 3, 2015 was $1.21 per share which totaled $803 for the 664,000 options granted during such period. During the year ended December 31, 2013, the weighted-average grant date fair value of options granted was $1.69 per share which totaled $588 for the 348,000 options granted during the year. A summary of the status of the Company's options as of January 3, 2015 and changes during the year then ended is presented below: Outstanding stock options expected to vest as of January 3, 2015 is 1,654,449. The intrinsic value of options exercised totaled $6 and $3 for the fiscal years ended January 3, 2015 and December 31, 2013, respectively. The following table summarizes information about stock options at January 3, 2015: F-20 Fiscal 2014 Fiscal 2013 Expected life (in years) 4.9 6.0 Risk-free interest rate 1.7 % 1.7 % Volatility 63.0 % 55.0 % Dividend yield 0.0 % 0.0 % Forfeiture rate 13.1 % 10.0 % Number Of Shares Weighted-Average Exercise Price Outstanding at beginning of year 1,409,812 $ 3.92 Granted 664,000 $ 2.24 Exercised (6,000 ) $ 3.16 Canceled (338,447 ) $ 3.81 Outstanding at end of year 1,729,365 $ 3.30 ​ ​ ​ ​ ​ ​ Options exercisable at January 3, 2015 1,264,918 $ 3.43 ​ ​ ​ ​ ​ ​ Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Remaining Contractual Life (years) Weighted Average Exercise Price Number Exercisable Remaining Contractual Life Weighted Average Exercise Price $1.89 - $2.00 194,750 9.2 $ 1.86 29,750 9.0 $ 1.85 $2.01 - $3.00 777,000 4.9 $ 2.20 730,656 4.7 $ 2.19 $3.01 - $4.00 265,063 7.2 $ 3.34 59,315 6.6 $ 3.38 $4.01 - $5.00 2,000 9.6 $ 4.06 0 NA NA $5.01 - $6.00 407,002 3.3 $ 5.33 364,947 3.2 $ 5.30 $6.01 - $8.00 83,550 6.3 $ 6.94 80,250 6.3 $ 6.90 1,729,365 5.4 $ 3.30 1,264,918 4.6 $ 3.43 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 6. SHARE BASED COMPENSATION (Continued) The aggregate intrinsic value of options outstanding and exercisable at January 3, 2015 and December 31, 2013 are $886 and $3, respectively. As of January 3, 2015, there was approximately $471 of unrecognized compensation cost related to non-vested stock option awards, which is expected to be recognized over a remaining weighted-average vesting period of 2.5 years. Restricted stock awards require no payment from the grantee. The related compensation cost of each award is calculated using the market price on the grant date and is expensed equally over the vesting period. A summary of restricted stock awards made in the year ended January 3, 2015, is as follows: As of January 3, 2015, there was approximately $455 of unrecognized compensation cost related to non-vested stock compensation arrangements granted under the Company's stock incentive plan for restricted stock awards. That cost is expected to be recognized over the next 2.4 years. As of January 3, 2015, there are 230,744 shares available to grant under the 2006 Plan and 636,375 shares available to grant under the 2012 Plan. 7. CAPITAL LEASE OBLIGATIONS The Company leases certain equipment under capital leases which expire over the next several years. The leases require monthly payments of principal and interest, imputed at interest rates ranging from 3% to 18% per annum. The capital lease liability balance of approximately $211 and $678 is included in debt on the consolidated balance sheets as of January 3, 2015 and December 31, 2013, respectively, of which approximately $70 and $228 is included in long-term liabilities as of January 3, 2015 and December 31, F-21 Number of Options Weighted Average Exercise Price Weighted Average Grant Date Fair Value Non-vested options at December 31, 2013 467,668 $ 4.04 $ 2.13 Options granted 664,000 2.24 1.21 Options vested (221,239 ) 3.21 1.72 Options forfeited (445,982 ) 2.93 1.55 Non-vested options at January 3, 2015 464,447 $ 2.93 $ 1.57 ​ ​ ​ ​ ​ ​ ​ ​ Number of Shares Grant Date Fair Value Non-Vested restricted stock awards as of December 31, 2013 268,361 $ 4.09 Granted 237,064 2.66 Vested (152,010 ) 3.90 Forfeited (111,166 ) 3.18 Non-Vested restricted stock awards as of January 3, 2015 242,249 $ 3.22 Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 7. CAPITAL LEASE OBLIGATIONS (Continued) 2013, respectively, and the balance is in current portion of long-term debt. The minimum future lease payments, including principal and interest, are approximately $219 and $715, respectively. Future Minimum Lease Payments 8. PROFIT SHARING PLAN Summer Infant (USA), Inc. maintains a defined contribution salary deferral plan under Section 401(k) of the Internal Revenue Code. All employees who meet the plan's eligibility requirements can participate. Employees may elect to make contributions up to 25% of their eligible compensation. In 2007, the Company adopted a matching plan which was funded throughout the year. For the years ended January 3, 2015 and December 31, 2013, the Company recorded 401(k) matching expense of $216 and $226, respectively. 9. MAJOR CUSTOMERS Sales to the Company's top seven customers together comprised more than 74% of the Company's sales in fiscal 2014 and 78% in 2013. These customers include Babies R Us/Toys R Us, Wal-Mart, Target, Amazon.com, Buy Buy Baby, K-Mart, and Burlington Coat Factory. Of these customers, four generated more than 10% of sales for fiscal 2014: Babies R Us/Toys R Us (27%), Walmart (14%), Target (11%), and Amazon.com (11%). In fiscal 2013, three customers generated more than 10% of sales: Babies R Us/Toys R Us (31%), Walmart (19%) and Target (11%). Because of the concentration of the Company's business with these customers and because it has no long term contracts with these customers, the Company's success depends on its customers' willingness to purchase and provide shelf space for its products. 10. COMMITMENTS AND CONTINGENCIES Royalty Commitments Summer Infant (USA), Inc. has entered into various license agreements with third parties for the use of product designs, software licenses, and trade names for the products manufactured by the Company. These agreements have termination dates through December 2017. Royalty expense under these licensing agreements for the years ended January 3, 2015 and December 31, 2013 were approximately $915 and $1,847, respectively. Customer Agreements The Company enters into annual agreements with its customers in the normal course of business. These agreements define the terms of product sales including, in some instances, cooperative advertising costs and product return privileges (for defective products only) or defective allowances F-22 Total 2015 2016 2017 2018 2019 & Beyond Capital Lease Payments $ 219 $ 147 $ 72 $ — $ — $ — Interest (7 ) (6 ) (1 ) (—) (—) — Principal $ 212 $ 141 $ 71 $ — $ — $ — Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 10. COMMITMENTS AND CONTINGENCIES (Continued) (which are based upon historical experience). These contracts are generally annual in nature and obligate the Company only as to products actually sold to the customer. Lease Commitments For lease agreements with escalation clauses, the Company records the total rent to be paid under the lease on a straight-line basis over the term of the lease, with the difference between the expense recognized and the cash paid recorded as a deferred rent liability included in accounts payable and accrued expenses on the balance sheet for amounts to be recognized within twelve months and in other liabilities for amounts to be recognized after twelve months from the balance sheet date, in the consolidated balance sheets. Lease incentives are recorded as deferred rent at the beginning of the lease term and recognized as a reduction of rent expense over the term of the lease. Summer Infant Europe Limited leases office space under a non-cancelable operating lease agreement. This lease is for a five-year term through April 2017, and requires monthly payments of approximately $6. In addition, Summer Infant Europe Limited is required to pay its proportionate share of property taxes. Summer Infant Canada, Ltd. entered into a five-year lease for office and warehouse space under a non-cancelable operating lease agreement expiring June 2018. The Company is obligated as part of the lease to pay maintenance expenses as well as property taxes and insurance costs as defined in the agreement. Monthly payments are approximately $27 over the course of the lease term. Summer Infant Canada, Ltd. has the option to renew this lease for one additional period of five years under similar terms and conditions. Summer Infant (USA) Inc. entered into a 72 month lease in September 2010 for warehouse space under a non-cancelable operating lease agreement. The Company is obligated to pay certain common area maintenance charges including insurance and utilities. The initial lease term is 10 months of free rent followed by 6 monthly payments of approximately $64 and escalate over the course of the lease term. During November 2013, Summer Infant Asia entered into a two year office lease which requires monthly payments of $9 through October 2015. Approximate future minimum rental payments due under these leases are as follows(a): Rent expense (excluding taxes, fees and other charges) for the years ended January 3, 2015 and December 31, 2013 totaled approximately $1,902 and $1,915, respectively. F-23 Fiscal Year Ending: 2015 $ 1,936 2016 1,363 2017 339 2018 161 2019 — Total $ 3,799 ​ ​ ​ ​ (a) Amounts exclude payments for sales-leaseback transaction as described in Note 4. Table of Contents SUMMER INFANT, INC. AND SUBSIDIAIRES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 10. COMMITMENTS AND CONTINGENCIES (Continued) Employment Contracts In accordance with United Kingdom and EU law, Summer Infant Europe Limited has employment contracts with all of its employees. In connection with these contracts, Summer Infant Europe Limited is required to fund the individual pension contributions of certain employees at varying rates from 5% to 10% of the employee's annual salary, as part of their total compensation package. These pension contributions are expensed as incurred. There are no termination benefit provisions in these contracts. Litigation The Company is a party to routine litigation and administrative complaints incidental to its business. The Company does not believe that the resolution of any or all of such routine litigation and administrative complaints is like to have a material adverse effect on the Company's financial condition or results of operations. 11. GEOGRAPHICAL INFORMATION The Company sells products throughout the United States, Canada, and the United Kingdom, and various other parts of the world. The Company does not disclose product line revenues as it is not practicable for the Company to do so. The following is a table that presents net revenue by geographic area: The following is a table that presents total assets by geographic area: The following is a table that presents total long lived assets by geographic area: 12. SUBSEQUENT EVENTS The Company has evaluated all events or transactions that occurred after January 3, 2015 through the date of this Annual Report. No subsequent event disclosures are required. F-24 For the fiscal year ended January 3, 2015 December 31, 2013 United States $ 170,375 $ 174,253 All Other 34,984 33,920 $ 205,359 $ 208,173 ​ ​ ​ ​ ​ ​ January 3, 2015 December 31, 2013 United States $ 100,302 $ 94,033 All Other 22,165 21,334 $ 122,467 $ 115,367 ​ ​ ​ ​ ​ ​ January 3, 2015 December 31, 2013 United States $ 27,180 $ 30,858 All Other 7,944 7,262 $ 35,124 $ 38,120 ​ ​ ​ ​ ​ ​ Table of Contents Index to Exhibits Exhibit No. Description 2.1 Agreement and Plans of Reorganization, dated as of September 1, 2006, by and among KBL Healthcare Acquisition Corp. II, and its wholly owned subsidiary, SII Acquisition Inc., and Summer Infant, Inc., Summer Infant Europe Limited, Summer Infant Asia, Ltd. and their respective stockholders (Incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on September 5, 2006, SEC File No. 000- 51228) 2.2 Purchase and Sale Agreement, dated March 24, 2009, between Summer Infant (USA), Inc. and Faith Realty II, LLC (Incorporated by reference to Exhibit 2.1 to the Registrant's Quarterly Report on Form 10-Q/A filed on August 18, 2009, SEC File No. 001-33346) 2.3 Lease Agreement, dated March 24, 2009, between Summer Infant (USA), Inc. and Faith Realty II, LLC (Incorporated by reference to Exhibit 2.2 to the Registrant's Quarterly Report on Form 10-Q/A filed on August 18, 2009, SEC File No. 001-33346) 2.4 Agreement and Plan of Merger, dated as of April 18, 2008, by and among Summer Infant (USA), Inc., Kiddo Acquisition Co. Inc., and Kiddopotamus & Company and certain of its stockholders (Incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on April 24, 2008, SEC File No. 001-33346) 2.5 Stock Purchase Agreement, dated as of March 24, 2011, by and among the Registrant, Summer Infant (USA), Inc., Born Free Holdings Ltd., and each stockholder of Born Free Holdings Ltd. (Incorporated by reference to Exhibit 2.1 to the Registrant's Current Report on Form 8-K filed on March 28, 2011) 3.1 Amended and Restated Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 to the Registrant's Form 8-A filed on March 6, 2007, SEC File No. 001-33346) 3.2 Certificate of Amendment to Amended and Restated Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on June 7, 2010) 3.3 Certificate of Amendment to Amended and Restated Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 to the Registrant's Quarterly Report on Form 10-Q filed on August 14, 2014) 3.4 Amended and Restated Bylaws (Incorporated by reference to Exhibit 3.3 to the Registrant's Annual Report on Form 10-K filed on March 13, 2013) 4.1 Specimen Common Stock Certificate (Incorporated by reference to Exhibit 4.2 to the Registrant's Form 8-A filed on March 6, 2007, SEC File No. 001-33346) 10.1 Registration Rights Agreement by and among the Registrant, Jason Macari and Steven Gibree (Incorporated by reference to Exhibit 10.9 to the Registrant's Current Report on Form 8-K filed on September 5, 2006, SEC File No. 000-51228) 10.2 * 2006 Performance Equity Plan (Incorporated by reference to Appendix A to the Registrant's Definitive Proxy Statement on Schedule 14A filed on April 29, 2008, SEC File No. 001-33346) 10.3 Loan and Security Agreement, dated as of February 28, 2013, among the Registrant, Summer Infant (USA), Inc., the Guarantors from time to time a party thereto, the financial institutions part thereto from time to time as Lenders, Bank of America, N.A., as Agent, and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Sole Lead Arranger and Sole Book Runner (Incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on March 4, 2013) Table of Contents Exhibit No. Description 10.4 Amendment No. 1 to Loan and Security Agreement, dated April 10, 2013, among the Registrant and Summer Infant (USA), Inc. as Borrowers, Summer Infant Canada, Limited and Summer Infant Europe Limited, as Guarantors, and Bank of America, N.A., in its capacity as Lender and as Agent (Incorporated by reference to Exhibit 10.3 to the Registrant's Quarterly Report on Form 10-Q filed on November 14, 2013) 10.5 Amendment No. 2 to Loan and Security Agreement, dated November 8, 2013, among the Registrant and Summer Infant (USA), Inc., as Borrowers, Summer Infant Canada, Limited and Summer Infant Europe Limited, as Guarantors, the Lenders party to the Loan and Security Agreement, and Bank of America, N.A., in its capacity as Agent (Incorporated by reference to Exhibit 10.1 to the Registrant's Quarterly Report on Form 10-Q filed on November 14, 2013) 10.6 Amendment No. 3 and Waiver to Loan and Security Agreement, dated December 12, 2014, among the Registrant and Summer Infant (USA), Inc., as Borrowers, Summer Infant Canada, Limited and Summer Infant Europe Limited, as Guarantors, the Lenders party to the Loan and Security Agreement, and Bank of America, N.A., in its capacity as Agent 10.7 Term Loan Agreement, dated as of February 28, 2013, among Summer Infant (USA), Inc., as lead borrower, the Registrant, the Guarantors named therein, Salus Capital Partners, LLC, as Administrative Agent and Collateral Agent, and the other Lenders party thereto (Incorporated by reference to Exhibit 10.2 to the Registrant's Current Report on Form 8-K filed on March 4, 2013) 10.8 Amendment No. 1 to Term Loan Agreement, dated November 8, 2013, among the Registrant and Summer Infant (USA), as Borrowers, Summer Infant Canada, Limited and Summer Infant Europe Limited, as Guarantors, the Lenders party of the Term Loan Agreement and Salus Capital Partners, LLC, as Agent (Incorporated by reference to Exhibit 10.2 to the Registrant's Quarterly Report on Form 10-Q filed on November 14, 2013) 10.9 Amendment No. 2 to Term Loan Agreement, dated December 31, 2014, among the Registrant and Summer Infant (USA), as Borrowers, Summer Infant Canada, Limited and Summer Infant Europe Limited, as Guarantors, the Lenders party of the Term Loan Agreement and Salus Capital Partners, LLC, as Agent 10.10 Security Agreement, dated as of February 28, 2013, among Summer Infant, (USA), Inc., as lead borrower, the Registrant, the Guarantors named therein, and Salus Capital Partners, LLC, as Agent (Incorporated by reference to Exhibit 10.3 to the Registrant's Current Report on Form 8-K filed on March 4, 2013) 10.11 * 2012 Incentive Compensation Plan, as amended (Incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on August 14, 2014) 10.12 * Form of Change of Control Agreement with Chief Financial Officer, Chief Operating Officer and other key employees (Incorporated by reference to Exhibit 10.4 to the Registrant's Quarterly Report on Form 10-Q filed on November 14, 2013) 10.13 * Separation Agreement and Release, dated as of January 15, 2014, by and between the Registrant and Jason Macari (Incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on January 17, 2014) 10.14 * Employment Agreement, dated as of January 16, 2014, by and between Summer Infant, Inc. and Carol E. Bramson (Incorporated by reference to Exhibit 10.2 to the Registrant's Current Report on Form 8-K filed on January 17, 2014) Table of Contents Exhibit No. Description 10.15 * Summer Infant, Inc. Form of Indemnification Agreement (for officers and directors) (Incorporated by reference to Exhibit 10.3 to the Registrant's Current Report on Form 8-K filed on January 17, 2014) 10.16 * Offer Letter and Change of Control Agreement by and between the Registrant and Kenneth Price (Incorporated by reference to Exhibit 10.29 to the Registrant's Annual Report on Form 10-K filed on March 11, 2014) 10.17 * Separation Agreement and General Release, dated as of October 23, 2014, by and among the Registrant, Summer Infant (USA), Inc. and David Hemendinger 10.18 * Separation Agreement and General Release, dated as of November 6, 2014, by and among the Registrant, Summer Infant (USA), Inc. and Paul Francese 10.19 * Offer Letter and Change of Control Agreement by and between the Registrant and William E. Mote 21.1 List of Subsidiaries (Incorporated by reference to Exhibit 21.1 to the Registrant's Annual Report on Form 10-K filed on March 13, 2013) 23.1 Consent of Independent Registered Public Accounting Firm 31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002) 32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002) 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.LAB XBRL Taxonomy Extension Labels Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document * Management contract or compensatory plan or arrangement.   Exhibit 10.6 Execution Copy AMENDMENT NO. 3 AND WAIVER TO LOAN AND SECURITY AGREEMENT This AMENDMENT NO. 3 AND WAIVER TO LOAN AND SECURITY AGREEMENT (this “ Amendment ”) is dated as of December 12, 2014 by and among SUMMER INFANT, INC. and SUMMER INFANT (USA), INC., as “Borrowers” under the Loan Agreement referenced below (“ Borrowers ”), SUMMER INFANT CANADA, LIMITED and SUMMER INFANT EUROPE LIMITED, as “Guarantors” under the Loan Agreement referenced below (“ Guarantors ” and collectively with Borrowers, “ Obligors ”), the “Lenders” party to the Loan Agreement referenced below (“ Lenders ”), and BANK OF AMERICA, N.A., in its capacity as “Agent” for the Lenders under the Loan Agreement referenced below (“ Agent ”). WHEREAS, Obligors, Lenders and Agent are parties to that certain Loan and Security Agreement dated as of February 28, 2013, as previously amended (as the same may be further amended, restated, supplemented or otherwise modified from time to time, the “ Loan Agreement ”); and WHEREAS, pursuant to clause (f) of Section 10.1.2 of the Loan Agreement, Obligors are required to furnish to Agent and Lenders, not later than 30 days prior to the end of each Fiscal Year, projections of Borrowers’ consolidated balance sheets, results of operations, cash flow and Availability for the next Fiscal Year, month by month; and WHEREAS, Obligors have advised Agent that Obligors require additional time to deliver the projections of Borrowers’ consolidated balance sheets, results of operations, cash flow and Availability for Fiscal Year 2015 (the “ 2015 Projections ”); and WHEREAS, pursuant to Section 10.2.13 of the Loan Agreement, Obligors are not permitted to change their Fiscal Year or make a material change in accounting treatment or reporting practices; and WHEREAS, Obligors have advised Agent that Obligors desire (i) to adopt a 4-4-5 week fiscal calendar and (ii) to modify their Fiscal Year so that it generally ends on the Saturday that falls on or closest to December 31 of each year (collectively, the “ Fiscal Calendar Modifications ”); WHEREAS, (a) Obligors have requested that Agent and Lenders (i) waive the requirement under clause (f) of Section 1 0.1.2 of the Loan Agreement that Obligors deliver the 2015 Projections no later than 30 days prior to the end of Fiscal Year 2014, (ii) extend the date for delivery by Obligors of the 2015 Projections to February 15, 2015, (iii) amend clause (f) of Section 1 0.1.2 of the Loan Agreement to extend the date for delivery of projections of Borrowers’ consolidated balance sheets, results of operations, cash flow and Availability for each Fiscal Year hereafter until February 15th of each such Fiscal Year, (iv) waive Section 10.2.13 of the Loan Agreement to permit Obligors to make the Fiscal Calendar Modifications, and (v) amend certain provisions of the Loan Agreement to effectuate the Fiscal Calendar Modifications, and (b) Agent and Lenders have agreed to do so subject to the terms and conditions set forth herein; NOW, THEREFORE, in consideration of the foregoing and the agreements contained herein, each party hereto hereby agrees as follows: 1. Capitalized Terms . Capitalized terms used herein which are defined in the Loan Agreement have the same meanings herein as therein, except to the extent such terms are amended hereby.  2. Waiver and Extension of Delivery Date for 2015 Projections . In reliance upon the representations, warranties and covenants of Obligors set forth herein, Agent and Lenders hereby (a) waive the requirement under clause (f) of Section 1 0.1.2 of the Loan Agreement that Obligors deliver the 2015 Projections no later than 30 days prior to the end of Fiscal Year 2014, and (b) agree that the date for delivery by Obligors of the 2015 Projections shall be extended to February 15, 2015. Obligors hereby covenant and agree to furnish to Agent and Lenders the 2015 Projections no later than February 15, 2015. Obligors hereby further acknowledge and agree that (x) the foregoing waiver is limited solely to Obligors’ requirement under clause (f) of Section 10.1.2 of the Loan Agreement to deliver the 2015 Projections no later than 30 days prior to the end of Fiscal Year 2014, and (y) nothing herein shall be construed as a waiver of any other provision of the Loan Agreement. 3. Waiver to Permit Fiscal Calendar Modifications . In reliance upon the representations, warranties and covenants of Obligors set forth herein, Agent and Lenders hereby waive Section 10.2.13 of the Loan Agreement to permit Obligors (a) to adopt a 4-4-5 week fiscal calendar and (b) to modify their Fiscal Year so that it generally ends on the Saturday that falls on or closest to December 31 of each year. Obligors hereby acknowledge and agree that (x) the foregoing waiver of Section 10.2.13 is limited solely to the fiscal calendar and Fiscal Year changes described in the preceding sentence, and (y) nothing herein shall be construed as a waiver of any other provision of the Loan Agreement. 4. Amendments to Section 1.1 of the Loan Agreement . In reliance upon the representations, warranties and covenants of Obligors set forth herein, Agent and Lenders hereby agree with Obligors that Section 1.1 of the Loan Agreement shall be amended as follows: (a) by deleting the existing definitions of “Fiscal Quarter” and “Fiscal Year” and replacing them with the following new definitions: “ Fiscal Quarter : any fiscal quarter of any Fiscal Year, which fiscal quarter shall consist of thirteen weeks divided into three Fiscal Months of four, four and five weeks, which fiscal quarters shall generally end on the Saturday closest to the last day of March, June, September and December of each Fiscal Year in accordance with the fiscal accounting calendar of the Company and its Subsidiaries.” “ Fiscal Year : the fiscal year of Company and its Subsidiaries for accounting and tax purposes, generally ending on the Saturday closest to the last day of December of each year.” (b) by adding the following new definition of “Fiscal Month”: “ Fiscal Month: any fiscal month of any Fiscal Year, which fiscal month shall consist of either four or five weeks and generally end on the Saturday closest to the last day of each calendar month in accordance with the fiscal accounting calendar of the Company and its Subsidiaries.” 5. Amendment to Section 8.1 of the Loan Agreement . In reliance upon the representations, warranties and covenants of Obligors set forth herein, Agent and Lenders hereby agree with Obligors that Section 8.1 of the Loan Agreement shall be amended as follows: “ 8.1. Borrowing Base Certificates. Obligors shall deliver to Agent (and Agent shall promptly deliver same to Lenders) (i) by the fifteenth (15 ) day of each calendar month, and at such other times as Agent may request, a Borrowing Base Certificate setting forth the amounts of Accounts, Inventory, Eligible Accounts, Eligible Inventory, the Accounts Formula Amount, the Inventory Formula Amount, the Availability Reserve, the Borrowing Base, the 2 th  Revolver Exposure and Availability as of the most recently ended Fiscal Month, and (ii) by Wednesday of each week, an updated Borrowing Base Certificate (which updated Borrowing Base Certificate shall include updated calculations of the Borrowing Base and Availability as of the end of the most recently ended week based solely upon sales, collections and Loan activity since the last day of the Fiscal Month for which a monthly Borrowing Base Certificate shall have been prepared). All calculations of Availability in any Borrowing Base Certificate shall originally be made by Obligors and certified by a Senior Officer, provided that Agent may from time to time review and, in its Permitted Discretion, adjust any such calculation (a) to reflect its estimate of declines in value of any Collateral, due to collections received or otherwise; or (b) to the extent Agent believes that the calculation was not made in accordance with this Agreement or does not accurately reflect the Availability Reserve.” 6. Amendment to Section 8.2.1 of the Loan Agreement . In reliance upon the representations, warranties and covenants of Obligors set forth herein, Agent and Lenders hereby agree with Obligors that the second sentence of Section 8.2.1 of the Loan Agreement shall be amended to read as follows: “Each Obligor shall also provide to Agent, on or before the 15 day of each month, a detailed aged trial balance of all Accounts as of the end of the most recent Fiscal Month, specifying each Account’s Account Debtor name and address, amount, invoice date and due date, showing any discount, allowance, credit, authorized return or dispute, and including such proof of delivery, copies of invoices and invoice registers, copies of related documents, repayment histories, status reports and other information as Agent may reasonably request.” 7. Amendment to Section 8.3.1 of the Loan Agreement . In reliance upon the representations, warranties and covenants of Obligors set forth herein, Agent and Lenders hereby agree with Obligors that the first sentence of Section 8.3.1 of the Loan Agreement shall be amended to read as follows: “Each Obligor shall keep accurate and complete records of its Inventory, including costs and daily withdrawals and additions, and, prior to the 15th day after the end of each month, shall submit to Agent inventory and reconciliation reports for the most recently ended Fiscal Month in form satisfactory to Agent.” 8. Amendment to Section 10.1.2 of the Loan Agreement . In reliance upon the representations, warranties and covenants of Obligors set forth herein, Agent and Lenders hereby agree with Obligors that Section 10.1.2 of the Loan Agreement shall be amended by deleting existing clauses (c) and (f) of Section 10.1.2 and replacing them with the following new clauses (c) and (f): “(c) as soon as available, and in any event within 30 days after the end of each month, unaudited balance sheets as of the end of the most recent Fiscal Month and the related statements of income and cash flow for such Fiscal Month and for the portion of the Fiscal Year then elapsed, on consolidated and, to the extent applicable, consolidating bases for Obligors and Subsidiaries, setting forth in comparative form corresponding figures for the preceding Fiscal Year and certified by the chief financial officer of Borrower Agent as prepared in accordance with GAAP and fairly presenting the financial position and results of operations for such month and period, subject to normal year-end adjustments and the absence of footnotes;” “(f) not later than February 15th of each Fiscal Year, projections of Borrowers’ consolidated balance sheets, results of operations, cash flow and Availability for such Fiscal Year, on a Fiscal Month by Fiscal Month basis;” 3 th  9. No Default; Representations and Warranties, Etc. Obligors hereby represent, warrant and confirm that: (a) after giving effect to this Amendment all representations and warranties of Obligors in the Loan Agreement and the other Loan Documents are true and correct in all material respects on and as of the date hereof as if made on such date (except to the extent that such representations and warranties expressly relate to or are stated to have been made as of an earlier date, in which case, such representations and warranties shall be true and correct in all material respects as of such earlier date); (b) after giving effect to this Amendment, no Default or Event of Default has occurred and is continuing; and (c) the execution, delivery and performance by Obligors of this Amendment and all other documents, instruments and agreements executed and delivered in connection herewith or therewith (i) have been duly authorized by all necessary action on the part of Obligors (including any necessary shareholder consents or approvals), (ii) do not violate, conflict with or result in a default under and will not violate or conflict with or result in a default under any applicable law or regulation, any term or provision of the organizational documents of any Obligor or any term or provision of any material indenture, agreement or other instrument binding on any Obligor or any of its assets, and (iii) do not require the consent of any Person which has not been obtained. 10. Ratification and Confirmation . Obligors hereby ratify and confirm all of the terms and provisions of the Loan Agreement and the other Loan Documents and agree that all of such terms and provisions, as amended hereby, remain in full force and effect. Without limiting the generality of the foregoing, Obligors hereby acknowledge and confirm that all of the “Obligations” under and as defined in the Loan Agreement are valid and enforceable and are secured by and entitled to the benefits of the Loan Agreement and the other Loan Documents, and Obligors hereby ratify and confirm the grant of the liens and security interests in the Collateral in favor of Agent, for the benefit of itself and Lenders, pursuant to the Loan Agreement and the other Loan Documents, as security for the Obligations. 11. Conditions to Effectiveness of Amendment . This Amendment shall become effective as of the date when, and only when, Agent shall have received counterparts to this Amendment, duly executed by Agent, Lenders and Obligors. 12. Miscellaneous . (a) Except to the extent specifically amended hereby, the Loan Agreement, the other Loan Documents and all related documents shall remain in full force and effect. (b) This Amendment may be executed in any number of counterparts, each of which, when executed and delivered, shall be an original, but all counterparts shall together constitute one instrument. (c) Borrowers shall reimburse Agent for, or pay directly, all reasonable out-of-pocket costs and expenses of Agent (including, without limitation, the reasonable fees and expenses of Agent’s legal counsel) in connection with the preparation, negotiation, execution and delivery of this Amendment and the other Loan Documents, within 30 days of Borrowers’ receipt of invoices (in reasonably sufficient detail) setting forth such costs and expenses. (d) This Amendment shall be governed by the laws of the State of New York and shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. {Remainder of page intentionally left blank; signatures begin on the following page} 4  IN WITNESS WHEREOF, the parties hereto have executed this Amendment which shall be deemed to be a sealed instrument as of the date first above written. [Signature Page to Amendment No.3 and Waiver to Loan and Security Agreement] BORROWERS SUMMER INFANT, INC. By: /s/ Carol E. Bramson Name: Carol E. Bramson Title: CEO SUMMER INFANT (USA), INC. By: /s/ Carol E. Bramson Name: Carol E. Bramson Title: CEO GUARANTORS SUMMER INFANT CANADA, LIMITED By: /s/ Carol E. Bramson Name: Carol E. Bramson Title: CEO SUMMER INFANT EUROPE LIMITED By: /s/ Carol E. Bramson Name: Carol E. Bramson Title: CEO  [Signature Page to Amendment No.3 and Waiver to Loan and Security Agreement] AGENT BANK OF AMERICA, N.A., as Agent By: /s/ Cynthia G. Stannard Name: Cynthia G. Stannard Title: Senior Vice President  [Signature Page to Amendment No.3 and Waiver to Loan and Security Agreement] LENDER BANK OF AMERICA, N.A., as Lender By: /s/ Cynthia G. Stannard Name: Cynthia G. Stannard Title: Senior Vice President  [Signature Page to Amendment No.3 and Waiver to Loan and Security Agreement] LENDER JPMORGAN CHASE BANK, N.A., as Lender By: /s/ Salvatore P. Demma Name: Salvatore P. Demma Title: Authorized Officer  [Signature Page to Amendment No.3 and Waiver to Loan and Security Agreement] LENDER FIRST NIAGARA COMMERCIAL FINANCE, INC., A WHOLLY-OWNED SUBSIDIARY OF FIRST NIAGARA BANK, N.A., as Lender By: /s/ Danielle Prentis Name: Danielle Prentis Title: Vice President — Portfolio Manager  Exhibit 10.9 Execution Copy AMENDMENT NO. 2 TO TERM LOAN AGREEMENT This AMENDMENT NO. 2 TO TERM LOAN AGREEMENT (this “ Amendment ”) is dated as of December 31, 2014 by and among SUMMER INFANT, INC. and SUMMER INFANT (USA), INC., as “Borrowers” under the Loan Agreement referenced below (“ Borrowers ”), SUMMER INFANT CANADA, LIMITED and SUMMER INFANT EUROPE LIMITED, as “Guarantors” under the Loan Agreement referenced below (“ Guarantors ”), the “Lenders” part to the Loan Agreement referenced below (“ Lenders ”), and SALUS CAPITAL PARTNERS, LLC, in its capacity as “Agent” for the Lenders under the Loan Agreement referenced below (“ Agent ”). WHEREAS, Borrowers, Guarantors, Lenders and Agent are parties to that certain Term Loan Agreement dated as of February 28, 2013, as previously amended (as the same may be amended, restated, supplemented or otherwise modified from time to time, the “ Loan Agreement ”); and WHEREAS, pursuant to clause (g) of Section 6.02 of the Loan Agreement, Loan Parties are required to furnish to Agent and Lenders, not later than 30 days prior to the end of each Fiscal Year, projections of Borrowers’ consolidated balance sheets, results of operations and cash flow for the next Fiscal Year, month by month; and WHEREAS, the Loan Parties have advised Agent that the Loan Parties require additional time to deliver the projections of Borrowers’ consolidated balance sheets, results of operations and cash flow for Fiscal Year 2015 (the “ 2015 Projections ”); and WHEREAS, pursuant to Section 7.14 of the Loan Agreement, the Loan Parties are not permitted to change their Fiscal Year or make a material change in accounting treatment or reporting practices; and WHEREAS, the Loan Parties have advised Agent that the Loan Parties desire (i) to adopt a 4-4-5 week fiscal calendar and (ii) to modify their Fiscal Year so that it generally ends on the Saturday that falls on or closest to December 31 of each year (collectively, the “ Fiscal Calendar Modifications ”); and WHEREAS, (a) the Loan Parties have requested that Agent and Lenders (i) waive the requirement under clause (g) of Section 6.02 of the Loan Agreement that the Loan Parties deliver the 2015 Projections no later than 30 days prior to the end of Fiscal Year 2014, (ii) extend the date for delivery by the Loan Parties of the 2015 Projections to January 31, 2015, (iii) amend clause (g) of Section6.02 of the Loan Agreement to extend the date for delivery of projections of Borrowers’ consolidated balance sheets, results of operations and cash flow for each Fiscal Year hereafter until January 31 of each such Fiscal Year, (iv) waive Section 7.14 of the Loan Agreement to permit the Loan Parties to make the Fiscal Calendar Modifications, and (v) amend certain provisions of the Loan Agreement to effectuate the Fiscal Calendar Modifications, and (b) Agent and Lenders have agreed to do so subject to the terms and conditions set forth herein; NOW, THEREFORE, in consideration of the foregoing and the agreements contained herein, each party hereto hereby agrees as follows: 1. Capitalized Terms . Capitalized terms used herein which are defined in the Loan Agreement have the same meanings herein as therein, except to the extent such terms are amended hereby. st  2. Waiver and Extension of Delivery Date for 2015 Projections . In reliance upon the representations, warranties and covenants of the Loan Parties set forth herein, Agent and Lenders hereby (a) waive the requirement under clause (g) of Section 6.02 of the Loan Agreement that the Loan Parties deliver the 2015 Projections no later than 30 days prior to the end of Fiscal Year 2014, and (b) agree that the date for delivery by the Loan Parties of the 2015 Projections shall be extended to January 31, 2015. The Loan Parties hereby covenant and agree to furnish to Agent and Lenders the 2015 Projections no later than January 31, 2015. The Loan Parties hereby further acknowledge and agree that (x) the foregoing waiver is limited solely to the Loan Parties’ requirement under clause (g) of Section 6.02 of the Loan Agreement to deliver the 2015 Projections no later than 30 days prior to the end of Fiscal Year 2014, and (y) nothing herein shall be construed as a waiver of any other provision of the Loan Agreement. 3. Waiver to Permit Fiscal Calendar Modifications . In reliance upon the representations, warranties and covenants of the Loan Parties set forth herein, Agent and Lenders hereby waive Section 7.14 of the Loan Agreement to permit the Loan Parties (a) to adopt a 4-4-5 week fiscal calendar and (b) to modify their Fiscal Year so that it generally ends on the Saturday that falls on or closest to December 31 of each year. The Loan Parties hereby acknowledge and agree that (x) the foregoing waiver of Section 7.14 is limited solely to the fiscal calendar and Fiscal Year changes described in the preceding sentence, and (y) nothing herein shall be construed as a waiver of any other provision of the Loan Agreement. 4. Amendments to Section 1.01 of the Loan Agreement . In reliance upon the representations, warranties and covenants of the Loan Parties set forth herein, Agent and Lenders hereby agree with the Loan Parties that Section 1.01 of the Loan Agreement shall be amended by deleting the existing definitions of “Fiscal Month,” “Fiscal Quarter” and “Fiscal Year” and replacing them with the following new definitions: “Fiscal Month” means any fiscal month of any Fiscal Year, which fiscal month shall consist of either four or five weeks and generally end on the Saturday closest to the last day of each calendar month in accordance with the fiscal accounting calendar of the Parent and its Subsidiaries. “Fiscal Quarter” means any fiscal quarter of any Fiscal Year, which fiscal quarter shall consist of thirteen weeks divided into three Fiscal Months of four, four and five weeks, which fiscal quarters shall generally end on the Saturday closest to the last day of March, June, September and December of each Fiscal Year in accordance with the fiscal accounting calendar of the Parent and its Subsidiaries. “Fiscal Year” means the fiscal year of Parent and its Subsidiaries for accounting and tax purposes, generally ending on the Saturday closest to the last day of December of each year. 5. Amendment to Section 6.02 of the Loan Agreement . In reliance upon the representations, warranties and covenants of the Loan Parties set forth herein, Agent and Lenders hereby agree with the Loan Parties that Section 6.02 of the Loan Agreement shall be amended by deleting existing clauses (c) and (g) of Section 6.02 and replacing them with the following new clauses (c) and (g): “(c) as soon as available, and in any event within 30 days after the end of each month, unaudited balance sheets as of the end of the most recent Fiscal Month and the related statements of income and cash flow for such Fiscal Month and for the portion of the 2  Fiscal Year then elapsed, on consolidated and, to the extent applicable, consolidating bases for the Loan Parties and Subsidiaries, setting forth in comparative form corresponding figures for the preceding Fiscal Year and certified by the chief financial officer of Lead Borrower as prepared in accordance with GAAP and fairly presenting the financial position and results of operations for such month and period, subject to normal year-end adjustments and the absence of footnotes;” “(g) not later than January 31st of each Fiscal Year, projections of Borrowers’ consolidated balance sheets, results of operations and cash flow for such Fiscal Year, on a Fiscal Month by Fiscal Month basis;” 6. Amendment to Section 7.24 of the Loan Agreement . In reliance upon the representations, warranties and covenants of the Loan Parties set forth herein, Agent and Lenders hereby agree with the Loan Parties that Section 7.24 of the Loan Agreement shall be amended by deleting the proviso at the end thereof and replacing it with the following proviso: “ provided , that the maximum Senior Leverage Ratio shall be established by the Agent for the period commencing on January 31, 2015 and thereafter, based upon the Business Plan; provided , further, that until the Agent has received a copy of the Business Plan for such subsequent Fiscal Year and established the maximum Senior Leverage Ratio based thereon, the maximum Senior Leverage Ratio shall remain at the same level as the immediately preceding period.” 7. No Default; Representations and Warranties, Etc. The Loan Parties hereby represent, warrant and confirm that: (a) after giving effect to this Amendment all representations and warranties of the Loan Parties in the Loan Agreement and the other Loan Documents are true and correct in all material respects on and as of the date hereof as if made on such date (except to the extent that such representations and warranties expressly relate to or are stated to have been made as of an earlier date, in which case, such representations and warranties shall be true and correct in all material respects as of such earlier date); (b) after giving effect to this Amendment, no Default or Event of Default has occurred and is continuing; and (c) the execution, delivery and performance by the Loan Parties of this Amendment and all other documents, instruments and agreements executed and delivered in connection herewith or therewith (i) have been duly authorized by all necessary action on the part of the Loan Parties (including any necessary shareholder consents or approvals), (ii) do not violate, conflict with or result in a default under and will not violate or conflict with or result in a default under any applicable law or regulation, any term or provision of the organizational documents of any Loan Party or any term or provision of any material indenture, agreement or other instrument binding on any Loan Party or any of its assets, and (iii) do not require the consent of any Person which has not been obtained. 8. Ratification and Confirmation . The Loan Parties hereby ratify and confirm all of the terms and provisions of the Loan Agreement and the other Loan Documents and agree that all of such terms and provisions, as amended hereby, remain in full force and effect. Without limiting the generality of the foregoing, the Loan Parties hereby acknowledge and confirm that all of the “Obligations” under and as defined in the Loan Agreement are valid and enforceable and are secured by and entitled to the benefits of the Loan Agreement and the other Loan Documents, and the Loan Parties hereby ratify and confirm the grant of the liens and security interests in the Collateral in favor of Agent, for the benefit of itself and Lenders, pursuant to the Loan Agreement and the other Loan Documents, as security for the Obligations. 3  9. Conditions to Effectiveness of Amendment . This Amendment shall become effective as of the date when, and only when, Agent shall have received counterparts to this Amendment, duly executed by Agent, Lenders and the Loan Parties. 10. Miscellaneous . (a) Except to the extent specifically amended hereby, the Loan Agreement, the other Loan Documents and all related documents shall remain in full force and effect. (b) This Amendment may be executed in any number of counterparts, each of which, when executed and delivered, shall be an original, but all counterparts shall together constitute one instrument. (c) Borrowers shall reimburse Agent for, or pay directly, all reasonable out-of-pocket costs and expenses of Agent (including, without limitation, the reasonable fees and expenses of Agent’s legal counsel) in connection with the preparation, negotiation, execution and delivery of this Amendment and the other Loan Documents, within 30 days of Borrowers’ receipt of invoices (in reasonably sufficient detail) setting forth such costs and expenses. (d) This Amendment shall be governed by the laws of the State of New York and shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. {Remainder of page intentionally left blank; signatures begin on the following page} 4  IN WITNESS WHEREOF, the parties hereto have executed this Amendment which shall be deemed to be a sealed instrument as of the date first above written. [Signature Page to Amendment No.2 to Term Loan Agreement] BORROWERS SUMMER INFANT, INC. By: /s/ Carol E. Bramson Name: Carol E. Bramson Title: Chief Executive Officer SUMMER INFANT (USA), INC. By: /s/ Carol E. Bramson Name: Carol E. Bramson Title: Chief Executive Officer GUARANTORS SUMMER INFANT CANADA, LIMITED By: /s/ Carol E. Bramson Name: Carol E. Bramson Title: Chief Executive Officer SUMMER INFANT EUROPE LIMITED By: /s/ Carol E. Bramson Name: Carol E. Bramson Title: Chief Executive Officer  [Signature Page to Amendment No.2 to Term Loan Agreement] AGENT SALUS CAPITAL PARTNERS, LLC, as Agent By: /s/ Macy Kiley Name: Macy Kiley Title: EVP By: /s/ Kyle C. Shonak Name: Kyle C. Shonak Title: Executive Vice President  [Signature Page to Amendment No.2 to Term Loan Agreement] LENDER SALUS CLO 2012-1, LTD., as Lender By: /s/ Macy Kiley Name: Macy Kiley Title: EVP By: /s/ Kyle C. Shonak Name: Kyle C. Shonak Title: Executive Vice President  Exhibit 10.17 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (“Agreement”) is made this 23rd day of October, 2014, by and among Summer Infant (USA), Inc. (“SI USA”), Summer Infant, Inc. (“SII”, and together with SI USA the “Company”) and David Hemendinger (“Hemendinger”). RECITALS This Agreement is made in light of, and in consideration of, the following facts and circumstances which form a material part of this Agreement: A. Since November 21, 2011, Hemendinger has been employed by the Company in various positions, including most recently as Chief Information Officer. B. Hemendinger is a party to a Non-Competition, Non-Disclosure and Developments Agreement dated July 1, 2013 (“Restrictive Agreement”), a copy of which is attached hereto as Exhibit A. C. The Company and Hemendinger have mutually agreed upon Hemendinger’s resignation from employment and that Hemendinger’s last day of employment shall be October 24, 2014. NOW, THEREFORE, in consideration of the mutual promises set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 1. Hemendinger and the Company agree that the last date of Hemendinger’s employment is October 24, 2014 (the “Separation Date”) at which time Hemendinger shall be removed from all offices and directorships held in the Company and any subsidiaries of the Company. Hemendinger will be paid all earned wages, accrued but unpaid vacation benefits, and reimbursements through the Separation Date by the next regular pay date after the Separation Date. 2. In accordance with the provisions of Section 2 (b) (i) of the Restrictive Agreement, the Company does hereby and herewith notify Hemendinger that it will exercise its right to extend the Non-Compete Period (as defined in the Restrictive Agreement) from and after the Separation Date for a period of twelve (12) weeks (the “Twelve Week Period”). The Company acknowledges and agrees that as a result of its exercise of its right to extend the Non-Compete Period (as defined in the Restrictive Agreement), Hemendinger is entitled to receive the consideration set forth in Section 2(b)(i) of the Restrictive Agreement; specifically, an amount equal to fifty-percent (50%) of Hemendinger’s base salary during the 12-week non-compete period, payable in bi-weekly installments on such dates as his  base salary would otherwise be paid by the Company in accordance with its regular payroll procedures, less applicable deductions and withholdings and an additional amount equal to fifty-percent (50%) of Hemendinger’s base salary during the four weeks immediately following the Twelve Week Period, payable in bi-weekly installments on such dates as his base salary would otherwise be paid by the Company in accordance with its regular payroll procedures, less applicable deductions and withholdings. Payment will commence on the next regular pay day following the Effective Date as defined in Paragraph 8(c). All provisions of the Restrictive Agreement that survive the termination of Hemendinger’s employment shall remain in full force and effect and Hemendinger does hereby acknowledge his obligations under the Restrictive Agreement and agrees to honor and abide by the terms thereof. 3. In consideration of the execution, delivery, non-revocation of this Agreement by Hemendinger and in consideration of the covenants and promises of Hemendinger set forth herein, including, without limitation, the release provided by Hemendinger to the Company pursuant to Paragraph 8 below (the “Release”), the Company shall provide to Hemendinger the following separation consideration (“Release Consideration”): (a) For a period of sixteen (16) weeks commencing on the next regular pay day following the Effective Date as defined in Paragraph 8(c), the Company shall pay to Hemendinger an amount equal to fifty-percent (50%) of his base salary, payable in bi-weekly installments on such dates as his base salary would otherwise be paid by the Company in accordance with its regular payroll procedures, less applicable deductions and withholdings (for the avoidance of doubt, the payments set forth in Paragraph 2 and this paragraph 3(a) are separate payments which together total sixteen (16) weeks of full base salary); (b) The Company agrees to the immediate vesting of five-thousand (5,000) restricted shares of stock under the award originally granted on November 21, 2011, and ten-thousand (10,000) shares of stock options under the award originally granted November 21, 2011. In addition, the Company agrees that the exercise period for Hemendinger’s vested and outstanding stock options will be extended for an additional six (6) months from the expiration date set forth in the relevant equity plan covering the options. The amended expiration date is July 25, 2015. Mr. Hemendinger’s ability to sell such restricted stock and/or exercise such options and sell such shares and/or engage in “cashless” transactions shall not be subject to any “blackout” or similar restrictions beginning on the third trading day after public release of the Company’s results for the quarter ended September 30, 2014; and (c) The Company will provide, at its expense, for Hemendinger to receive outplacement services with an outplacement provider used by the Company for a period of up to twelve (12) months following the Effective Date as defined in Paragraph 8(c) of this Agreement. (d) The Separation Date shall be the date of the “qualifying event” under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) and the Company will present Hemendinger with information on COBRA under separate cover. 4. Hemendinger understands, acknowledges and agrees that he is receiving the Release Consideration set forth in Paragraph 3 in exchange for the Release set forth in Paragraph 7 and his agreement to honor and abide by the terms and conditions of this Agreement, and is otherwise not entitled to receive the Release Consideration. 2  5. Hemendinger acknowledges and agrees that his participation in the Company’s 401(k) plan and his rights to benefits under that plan following the Separation Date will be governed by the terms of that plan. 6. Except as set forth in this Agreement, Hemendinger acknowledges that any outstanding unvested awards under any plan(s) maintained by the Company shall be treated in accordance with the rules of the relevant plan and the terms of the relevant award. 7. The release (“Release”) set forth in this Paragraph 7 is effective as of the Effective Date of this Agreement. (a) In exchange for the consideration set forth in Paragraph 3, Hemendinger for himself and his agents, attorneys, successors, and assigns, hereby releases and forever discharges the Company and its present and/or former parents, affiliates, divisions, subsidiaries, predecessors, successors and assigns as well as its and/or their present and former officers, directors, shareholders, agents, counsel, insurers, and employees (collectively the “Releasees”), to the fullest extent permitted by law, of and from all actions, causes of action, suits, debts, dues, sums of money, damages, judgments, executions, claims and demands which may be legally waived by private agreement, in law or in equity, known or unknown, foreseen or unforeseen, which he ever had, now has or which his heirs, executors, administrators, successors and assigns (collectively with Hemendinger, the “Releasors”) hereafter shall, can or may have, upon or by reason of any matter, cause or thing arising at any time up to the date of Hemendinger’s execution of this Agreement. (b) The foregoing release by Releasors includes, but is not limited to, any and all claims, individual or collective, arising on or before Hemendinger’s execution of this Agreement under the Age Discrimination in Employment Act of 1967, as amended, 29 U.S.C. § 621 et seq., Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000 et seq., the Civil Rights Act of 1871, as amended, 42 U.S.C. § 1981 et seq., the Americans with Disabilities Act, 42 U.S.C. § 12101 et seq., the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. § 1001 et seq., Family and Medical Leave Act, 29 U.S.C. §2601 et seq. and all other federal, state and local laws, including but not limited to the Rhode Island Fair Employment Practices Act, R.I. Gen. Laws §§ 28-5-1 et seq., the Rhode Island Civil Rights Act of 1990, R.I. Gen. Laws §§ 42-112-1 et seq., the Civil Rights of People with Disabilities Act, R.I. Gen. Laws §§ 42-87-1 et seq., the Rhode Island Parental and Family Medical Leave Act, R.I. Gen. Laws §§ 28-48-1 et seq., Rhode Island wage payment laws, any Executive Orders (governing employment practices) which may affect the Company, and all other federal, state and local laws, as each of the foregoing have been or may be amended, and any and all claims arising under any other federal, state or local statute, law, rule, regulation, or decision, including claims for discrimination, harassment, retaliation, breach of contract, infliction of emotional distress, negligence, defamation or slander, wrongful discharge in violation of public policy, and any and all other common law claims, as well as any and all claims for attorneys’ fees and costs. (c) Hemendinger acknowledges and agrees that the Release Consideration he is receiving under this Agreement is sufficient consideration to support the release of all entities and persons identified in this Paragraph 7(a) of this Agreement, and that said Release Consideration is in addition to anything of value to which Hemendinger is entitled. 3  (d) Hemendinger agrees that he will not sue on, or commence any proceedings relating to, any claim which would be released by this Agreement, other than his participation in a governmental or state agency investigation or proceeding as described in Paragraph 9. If he subsequently contests this Agreement for any reason, Hemendinger agrees to first tender back to the Company the payment being made to him under Paragraph 3. Hemendinger agrees and represents that he has not filed, or caused to be filed, any claim or charge with any court, adjudicative body, regulatory body, or agency arising out of his employment or termination of employment. (e) Hemendinger agrees and represents that: (i) he has received all leave (paid or unpaid), compensation, wages, overtime if applicable, bonuses, commissions, and/or benefits to which he may be entitled and that no other amounts and/or benefits are due except as expressly provided in this Agreement; (ii) has no known workplace injuries or occupational diseases that he has not already reported to Company; (iii) has either been provided or not been denied any leave requested under the Family and Medical Leave Act or state law; (iv) is not eligible to receive payments or benefits under any other severance pay policy, plan, practice or arrangement of the Company other than as set forth herein; and (v) has not complained of and is not aware of any fraudulent activity or any act(s) which would form the basis of a claim of fraudulent or illegal activity by the Company. (f) Hemendinger further waives and releases any right to become, and agrees not to consent to become, a member of any class in a case in which claims are asserted against the Company or the Releasees that are related in any way to Hemendinger’s employment or the termination of his employment with Company. If, without his prior knowledge and consent, Hemendinger is made a member of a class in any proceeding, he agrees to opt out of the class at the first opportunity. 8. Age Discrimination in Employment Act (“ADEA”) . Because Hemendinger is 40 years of age or older, the Company is advising Hemendinger of, and Hemendinger acknowledges, the following: (a) Twenty-One (21) Day Consideration Period . Hemendinger shall have twenty-one (21) days to consider and accept the terms of this Agreement by fully executing it below, and returning it to the Company to Mark Strozik’s attention at the address provided in Paragraph 12. During this twenty-one (21) day period and before signing this Agreement, Hemendinger is encouraged to consult with an attorney regarding the terms and provisions of this Agreement at his own expense. Hemendinger may sign the Agreement of his own volition prior to the conclusion of the twenty-one (21) day period. (b) Release of Age Discrimination in Employment Act Claims . By signing this Agreement, Hemendinger waives any claims he has or might have against the Company or the Releasees under the ADEA that accrued prior to the date of Hemendinger’s execution of the Agreement. (c) Revocation Period . Hemendinger shall have seven (7) days from the date he signs this Agreement to change his mind and revoke the agreement to waive claims of discrimination under the ADEA. This seven-day right of revocation does not apply to any 4  other type of claim covered by the release in Paragraph 7 above. Any revocation within this period must state “I hereby revoke my acceptance of our Agreement and General Release related to claims under the Age Discrimination in Employment Act.” The written revocation must be delivered to provide written notice of revocation of this Agreement to Mark Strozik’s attention, at the address provided in Paragraph 12 and must be postmarked within seven (7) calendar days of Hemendinger’s execution of this Agreement. If Hemendinger does not revoke this Agreement prior to the expiration of this seven (7) day period, this Agreement shall take effect at that time as a legally binding agreement between Hemendinger and the Company on the basis set forth herein (the “Effective Date”). HEMENDINGER IS HEREBY ADVISED THAT HE HAS UP TO TWENTY-ONE (21) CALENDAR DAYS TO REVIEW AND CONSIDER THIS AGREEMENT AND IS HEREBY ADVISED IN WRITING TO CONSULT WITH AN ATTORNEY PRIOR TO EXECUTION OF THIS AGREEMENT. HEMENDINGER AGREES THAT ANY MODIFICATIONS, MATERIAL OR OTHERWISE, MADE TO THIS AGREEMENT DO NOT RESTART OR AFFECT IN ANY MANNER THE ORIGINAL TWENTY-ONE (21) CALENDAR DAY CONSIDERATION PERIOD. HAVING ELECTED TO EXECUTE THIS AGREEMENT, TO FULFILL THE PROMISES AND TO RECEIVE THE SUMS AND BENEFITS IN PARAGRAPH 3 ABOVE, HEMENDINGER FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTERS INTO THIS AGREEMENT INTENDING TO WAIVE, SETTLE AND RELEASE ALL CLAIMS HEMENDINGER HAS OR MIGHT HAVE AGAINST THE RELEASEES. 9. Nothing in this Agreement, including but not limited to the release of claims, proprietary information, confidentiality, cooperation, and non-disparagement provisions, prevents Hemendinger from filing a charge or complaint with or from participating in an investigation or proceeding conducted by the Equal Employment Opportunity Commission, National Labor Relations Board, or any other federal, state or local agency charged with the enforcement of any laws. By signing this Agreement, however, Hemendinger is waiving rights to individual relief based on claims asserted in such a charge or complaint, except where such a waiver of individual relief is prohibited. With respect to any claim that cannot be released by private agreement, Hemendinger agrees to release and waive his right (if any) to any monetary damages or other recovery as to such claims, including any claims brought on Hemendinger’s behalf, either individually or as part of a collective action, by any governmental agency or other third party. Notwithstanding the foregoing, this release Agreement does not prohibit or bar Hemendinger from providing truthful testimony in any legal proceeding or from cooperating with, or making truthful disclosures to, any governmental agency. Even though Hemendinger intends to release all claims that he may have existing at the time of, or that Hemendinger had prior to, the execution of this Agreement, this Agreement does not release Hemendinger’s right to (i) any vested 401(k) or other retirement 5  benefits to which he is or will be entitled, or (ii) any wages Hemendinger has earned on or before the date he executes this Agreement. This release does not extend to any claims Hemendinger has made or may make for workers’ compensation or unemployment compensation. Also, this Agreement does not release claims that cannot be released as a matter of law. For example, this Agreement does not release claims under the Fair Labor Standards Act of 1938. Finally, this Agreement does not release any claims which Mr. Hemendinger may have resulting from any breach of this Agreement by the Company. 10. From and after the Separation Date, Hemendinger shall not represent himself as an employee, officer, director or representative of the Company or attempt to conduct business in the name or on behalf of the Company or any of its subsidiaries. Upon the Separation Date, Hemendinger agrees to promptly return all items of Company property he has or over which he has control, including but not limited to all keys, records, lap top computer, cell phone, designs, business plans, financial statements, manuals, memoranda, lists, and other property delivered to or compiled by Hemendinger by or on behalf of the Company (or its subsidiaries) or its representatives, vendors, or customers that pertain to the business of the Company (or its subsidiaries), all equipment belonging to the Company, all code and computer programs and information of whatever nature, tools, manuals, and any and all other materials, documents or information, including but not limited to confidential information in his possession or control, and that he will retain no copies thereof. Likewise, all correspondence, reports, records, charts, advertising materials, and other similar data pertaining to the business, activities or future plans of the Company (or its subsidiaries) that has been collected by Hemendinger shall be delivered promptly to the Company upon the Separation Date. 11. Hemendinger and the Company (together referred to as the “Parties”) mutually agree to maintain in strict confidence, and not to disclose, the terms, conditions, amount, fact of, and circumstances leading to the making of this Agreement, and any and all actions taken in accordance with this Agreement, provided however, that : (a) Hemendinger may disclose this Agreement to his immediate family; (b) the Parties may disclose this Agreement in confidence to their respective attorneys, accountants, auditors, tax preparers, and financial advisors; (c) the Company may disclose this Agreement as necessary to Company employees for business-related reasons, or to others to fulfill standard or legally required corporate reporting or disclosure requirements; and (d) the Parties may disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law. Further, the Parties represent that they have not disclosed the fact of, or the terms of this Agreement and receipt of the payment described in Paragraph 3 to anyone, other than the permitted disclosures referenced above, at any time prior to execution of this Agreement. Hemendinger specifically acknowledges and agrees that he shall not disclose the terms or existence of this Agreement to any current or former Company employee in any manner, whether in writing or orally, directly or indirectly, or by or through an agent, representative, attorney or any other such person. In the event that any third party seeks to compel disclosure of this Agreement by service of a subpoena or otherwise, Hemendinger agrees to promptly notify the Company and to limit any response to the specific information sought. 6  12. All notices, requests, consents and other communications hereunder that are required to be provided, or that the sender elects to provide, in writing, will be addressed to the receiving party’s address set forth below or to such other address as a party may designate by notice hereunder, and will be either (i) delivered by hand, (ii) sent by overnight courier, or (iii) sent by registered or certified mail, return receipt requested, postage prepaid. 13. Hemendinger acknowledges, represents and warrants that he enters into this Agreement knowingly, voluntarily, free of duress or coercion, and with a full understanding of all terms and conditions contained herein. 14. Should any provision in this Agreement be declared or determined to be illegal or invalid the validity of the remaining parts, terms, or provisions shall not be affected and the illegal or invalid part, term, or provisions shall be deemed not to be part of this Agreement. 15. This Agreement and the agreements referenced herein, including the Restrictive Agreement, constitute the entire agreement between the parties, and supersede all oral negotiations and any prior and other writings with respect to the subject matter of this Agreement, and are intended by the parties as the final, complete and exclusive statement of the terms agreed to by them. 16. This Agreement shall be governed by and construed in accordance with the laws of the State of Rhode Island. 17. This Agreement shall be binding upon the parties and may not be amended, supplemented, changed, or modified in any manner, orally or otherwise, except by an instrument in writing of concurrent or subsequent date signed by the Company and Hemendinger. 18. Hemendinger agrees that he may not assign any of his rights or delegate any of his duties under this Agreement. The rights and obligations of the Company shall inure to the benefit of the Company’s successors and assigns. 19. This Agreement shall not in any way be construed as an admission by either the Company or Hemendinger that it or he has acted wrongfully with respect to the other and both the Company and Hemendinger specifically deny the commission of any wrongful acts against the other. 20. Hemendinger agrees that he will not make any written or oral statement or take any action which he knows or reasonably should know constitutes an untrue, 7 If to the Company: If to Hemendinger: Summer Infant (USA), Inc. David Hemendinger Summer Infant, Inc. [Address] 1275 Park East Drive Woonsocket, Rhode Island 02895 Attn: Mark Strozik, SVP/ Human Resources  disparaging, or negative comment concerning the Company. Hemendinger agrees to refer any prospective employer or other individual or entity seeking an employment or other reference from the Company to the Senior Vice President of Human Resources, who is currently Mark Strozik. The Senior Vice President of Human Resources will provide only a neutral reference confirming the dates of Hemendinger’s employment and his job title. Likewise, the Company agrees to instruct all current Corporate officers and current members of the Board of Directors not to make any written or oral statement or take any action which they know or reasonably should know constitutes an untrue, disparaging, or negative comment concerning Hemendinger. 21. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together constitute one and the same instrument. [Remainder of Page Intentionally Left Blank] 8  IN WITNESS WHEREOF, the parties execute this Agreement as of the date indicated below. I have read this Agreement and understand that if I sign it I will be giving up important rights. I have been given ample opportunity to consult with and review this Agreement with an attorney of my choice. By signing below, I acknowledge that I willingly, voluntarily, and knowingly accept and agree to all the terms and conditions of this Agreement. 9 /s/ David Hemendinger October 23, 2014 David Hemendinger Date EMPLOYEE ID: Summer Infant (USA), Inc. and Summer Infant, Inc. Mark Strozik By: /s/ Mark Strozik Title: SVP/ Human Resources Date: October 23, 2014 Attachments: Exhibit A: Non-Competition, Non-Disclosure and Developments Agreement dated July 1, 2013  Exhibit 10.18 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (“Agreement”) is made this 6th day of November, 2014, by and among Summer Infant (USA), Inc. (“SI USA”), Summer Infant, Inc. (“SII”, and together with SI USA the “Company”) and Paul Francese (“Francese”). RECITALS This Agreement is made in light of, and in consideration of, the following facts and circumstances which form a material part of this Agreement: A. Since September 10, 2012, Francese has been employed by the Company as Chief Financial Officer. B. Francese is a party to a Non-Competition, Non-Disclosure and Developments Agreement dated July 10, 2013 (“Restrictive Agreement”), a copy of which is attached hereto as Exhibit A. C. The Company and Francese have mutually agreed upon Francese’s resignation from employment and that Francese’s last day of employment shall be November 30, 2014. NOW, THEREFORE, in consideration of the mutual promises set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 1. Francese and the Company agree that the last date of Francese’s employment is November 30, 2014 (the “Separation Date”) at which time Francese shall resign from all offices and directorships held in the Company and any subsidiaries of the Company, provided that Francese shall no longer have the responsibilities as Chief Financial Officer of the Company as of November 10, 2014. Provided that Francese performs his obligations hereunder and does not revoke this Agreement as set forth in Paragraph 8(c), Francese will be employed as a full time employee and make himself available to the Company for reasonable transition purposes at the Company’s request during the period from the date hereof through the Separation Date. Francese will be paid all earned wages, accrued but unpaid vacation benefits, and reimbursements through the Separation Date by the next regular pay date after the Separation Date. 2. In accordance with the provisions of Section 2 (b) (i) of the Restrictive Agreement, the Company does hereby and herewith notify Francese that it will exercise its right to extend the Non-Compete Period (as defined in the Restrictive Agreement) from and after the Separation Date for a period commencing on December 1, 2014 and continuing through and including March 31, 2015 (the “Restricted Period”). The Company acknowledges and agrees that as a result of its exercise of its right to extend the Non-Compete Period (as defined in the Restrictive Agreement), Francese is entitled to receive the consideration set forth in Section 2(b)(i) of the Restrictive Agreement; specifically, an amount equal to fifty-percent (50%) of Francese’s base salary during the Restricted Period,  payable in bi-weekly installments on such dates as his base salary would otherwise be paid by the Company in accordance with its regular payroll procedures, less applicable deductions and withholdings. Payment will commence on the next regular pay day following November 30, 2014, provided that Francese has not revoked the Agreement as set forth in in Paragraph 8(c). All provisions of the Restrictive Agreement that survive the termination of Francese’s employment shall remain in full force and effect and Francese does hereby acknowledge his obligations under the Restrictive Agreement and agrees to honor and abide by the terms thereof. 3. In consideration of the execution, delivery, non-revocation of this Agreement by Francese and in consideration of the covenants and promises of Francese set forth herein, including, without limitation, the release provided by Francese to the Company pursuant to Paragraph 8 below (the “Release”), the Company shall provide to Francese the following separation consideration (“Release Consideration”): (a) For a period commencing on December 1, 2014 and continuing through and including March 31, 2015, the Company shall pay to Francese an amount equal to fifty-percent (50%) of his base salary (the “Severance Payments”). The Severance Payments will commence on the next regular pay day following November 30, 2014, provided Francese has not revoked the Agreement as set forth in Paragraph 8(c). The Severance Payments will be payable in bi-weekly installments on such dates as Francese’s base salary would otherwise be paid by the Company in accordance with its regular payroll procedures, less applicable deductions and withholdings; (b) The Company agrees to the immediate vesting of two thousand (2,000) restricted shares of stock under the award originally granted on March 4, 2014, and three thousand, seven hundred and fifty (3,750) shares of stock options under the award originally granted March 4, 2014. In addition, the Company agrees that the exercise period for Francese’s vested and outstanding stock options will be extended for an additional six (6) months from the expiration date set forth in the relevant equity plan covering the options, such expiration date now being August 30, 2015. Francese’s ability to sell such restricted stock and/or exercise such options and/or engage in “cashless” transactions shall be subject to any current Company-imposed “blackout” or similar restrictions; (c) Continuance for a period commencing on December 1 and continuing through and including March 31, 2015, of all medical, dental and vision health benefits which Francese has elected to receive from or through the Company as of October 31, 2014, on the same terms and with the same level of contributions required from both the Company and Francese, as existed on that date; (d) Pay out in an amount equivalent to any unused, accrued PTO time that Francese has as of the Separation Date; and (e) The Company will provide, at its expense, for Francese to receive outplacement services with an outplacement provider used by the Company for a period of up to twelve (12) months following the Effective Date as defined in Paragraph 8(c) of this Agreement. 2  (f) The Separation Date shall be the date of the “qualifying event” under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) and the Company will present Francese with information on COBRA under separate cover. 4. Francese understands, acknowledges and agrees that he is receiving the Release Consideration set forth in Paragraph 3 in exchange for the Release set forth in Paragraph 7 and his agreement to honor and abide by the terms and conditions of this Agreement, and is otherwise not entitled to receive the Release Consideration. 5. Francese acknowledges and agrees that his participation in the Company’s 401(k) plan and his rights to benefits under that plan following the Separation Date will be governed by the terms of that plan. 6. Except as set forth in this Agreement, Francese acknowledges that any outstanding unvested awards under any plan(s) maintained by the Company shall be treated in accordance with the rules of the relevant plan and the terms of the relevant award. 7. The release (“Release”) set forth in this Paragraph 7 is effective as of the Effective Date of this Agreement. (a) In exchange for the consideration set forth in Paragraph 3, Francese for himself and his agents, attorneys, successors, and assigns, hereby releases and forever discharges the Company and its present and/or former parents, affiliates, divisions, subsidiaries, predecessors, successors and assigns as well as its and/or their present and former officers, directors, shareholders, agents, counsel, insurers, and employees (collectively the “Releasees”), to the fullest extent permitted by law, of and from all actions, causes of action, suits, debts, dues, sums of money, damages, judgments, executions, claims and demands which may be legally waived by private agreement, in law or in equity, known or unknown, foreseen or unforeseen, which he ever had, now has or which his heirs, executors, administrators, successors and assigns (collectively with Francese, the “Releasors”) hereafter shall, can or may have, upon or by reason of any matter, cause or thing arising at any time up to the date of Francese’s execution of this Agreement. (b) The foregoing release by Releasors includes, but is not limited to, any and all claims, individual or collective, arising on or before Francese’s execution of this Agreement under the Age Discrimination in Employment Act of 1967, as amended, 29 U.S.C. § 621 et seq., Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000 et seq., the Civil Rights Act of 1871, as amended, 42 U.S.C. § 1981 et seq., the Americans with Disabilities Act, 42 U.S.C. § 12101 et seq., the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. § 1001 et seq., Family and Medical Leave Act, 29 U.S.C. §2601 et seq. and all other federal, state and local laws, including but not limited to the Rhode Island Fair Employment Practices Act, R.I. Gen. Laws §§ 28-5-1 et seq., the Rhode Island Civil Rights Act of 1990, R.I. Gen. Laws §§ 42-112-1 et seq., the Civil Rights of People with Disabilities Act, R.I. Gen. Laws §§ 42-87-1 et seq., the Rhode Island Parental and Family Medical Leave Act, R.I. Gen. Laws §§ 28-48-1 et seq., Rhode Island wage payment laws, any Executive Orders (governing employment practices) which may affect the Company, and all other federal, state and local laws, as each of the foregoing have been or may be amended, and any and all claims arising under any other federal, state or local statute, law, rule, regulation, or decision, including claims for discrimination, harassment, retaliation, 3  breach of contract, infliction of emotional distress, negligence, defamation or slander, wrongful discharge in violation of public policy, and any and all other common law claims, as well as any and all claims for attorneys’ fees and costs. (c) Francese acknowledges and agrees that the Release Consideration he is receiving under this Agreement is sufficient consideration to support the release of all entities and persons identified in this Paragraph 7(a) of this Agreement, and that said Release Consideration is in addition to anything of value to which Francese is entitled. (d) Francese agrees that he will not sue on, or commence any proceedings relating to, any claim which would be released by this Agreement, other than his participation in a governmental or state agency investigation or proceeding as described in Paragraph 9. If he subsequently contests this Agreement for any reason, Francese agrees to first tender back to the Company the payment being made to him under Paragraph 3. Francese agrees and represents that he has not filed, or caused to be filed, any claim or charge with any court, adjudicative body, regulatory body, or agency arising out of his employment or termination of employment. (e) Francese agrees and represents that: (i) he has received all leave (paid or unpaid), compensation, wages, overtime if applicable, bonuses, commissions, and/or benefits to which he may be entitled and that no other amounts and/or benefits are due except as expressly provided in this Agreement; (ii) has no known workplace injuries or occupational diseases that he has not already reported to Company; (iii) has either been provided or not been denied any leave requested under the Family and Medical Leave Act or state law; (iv) is not eligible to receive payments or benefits under any other severance pay policy, plan, practice or arrangement of the Company other than as set forth herein; and (v) has not complained of and is not aware of any fraudulent activity or any act(s) which would form the basis of a claim of fraudulent or illegal activity by the Company. (f) Francese further waives and releases any right to become, and agrees not to consent to become, a member of any class in a case in which claims are asserted against the Company or the Releasees that are related in any way to Francese’s employment or the termination of his employment with Company. If, without his prior knowledge and consent, Francese is made a member of a class in any proceeding, he agrees to opt out of the class at the first opportunity. 8. Age Discrimination in Employment Act (“ADEA”) . Because Francese is 40 years of age or older, the Company is advising Francese of, and Francese acknowledges, the following: (a) Twenty-One (21) Day Consideration Period . Francese shall have twenty-one (21) days to consider and accept the terms of this Agreement by fully executing it below, and returning it to the Company to Mark Strozik’s attention at the address provided in Paragraph 12. During this twenty-one (21) day period and before signing this Agreement, Francese is encouraged to consult with an attorney regarding the terms and provisions of this Agreement at his own expense. Francese may sign the Agreement of his own volition prior to the conclusion of the twenty-one (21) day period. 4  (b) Release of Age Discrimination in Employment Act Claims . By signing this Agreement, Francese waives any claims he has or might have against the Company or the Releasees under the ADEA that accrued prior to the date of Francese’s execution of the Agreement. (c) Revocation Period . Francese shall have seven (7) days from the date he signs this Agreement to change his mind and revoke the agreement to waive claims of discrimination under the ADEA. This seven-day right of revocation does not apply to any other type of claim covered by the release in Paragraph 7 above. Any revocation within this period must state “I hereby revoke my acceptance of our Agreement and General Release related to claims under the Age Discrimination in Employment Act.” The written revocation must be delivered to provide written notice of revocation of this Agreement to Mark Strozik’s attention, at the address provided in Paragraph 12 and must be postmarked within seven (7) calendar days of Francese’s execution of this Agreement. If Francese does not revoke this Agreement prior to the expiration of this seven (7) day period, this Agreement shall take effect at that time as a legally binding agreement between Francese and the Company on the basis set forth herein (the “Effective Date”). FRANCESE IS HEREBY ADVISED THAT HE HAS UP TO TWENTY-ONE (21) CALENDAR DAYS TO REVIEW AND CONSIDER THIS AGREEMENT AND IS HEREBY ADVISED IN WRITING TO CONSULT WITH AN ATTORNEY PRIOR TO EXECUTION OF THIS AGREEMENT. FRANCESE AGREES THAT ANY MODIFICATIONS, MATERIAL OR OTHERWISE, MADE TO THIS AGREEMENT DO NOT RESTART OR AFFECT IN ANY MANNER THE ORIGINAL TWENTY-ONE (21) CALENDAR DAY CONSIDERATION PERIOD. HAVING ELECTED TO EXECUTE THIS AGREEMENT, TO FULFILL THE PROMISES AND TO RECEIVE THE SUMS AND BENEFITS IN PARAGRAPH 3 ABOVE, FRANCESE FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTERS INTO THIS AGREEMENT INTENDING TO WAIVE, SETTLE AND RELEASE ALL CLAIMS FRANCESE HAS OR MIGHT HAVE AGAINST THE RELEASEES. 9. Nothing in this Agreement, including but not limited to the release of claims, proprietary information, confidentiality, cooperation, and non-disparagement provisions, prevents Francese from filing a charge or complaint with or from participating in an investigation or proceeding conducted by the Equal Employment Opportunity Commission, National Labor Relations Board, or any other federal, state or local agency charged with the enforcement of any laws. By signing this Agreement, however, Francese is waiving rights to individual relief based on claims asserted in such a charge or complaint, except where such a waiver of individual relief is prohibited. With respect to any claim that cannot be released by private agreement, Francese agrees to release and waive his right (if any) to any monetary damages or other recovery as to such claims, including any claims brought on Francese’s behalf, either individually or as part of a collective action, by any governmental agency or 5  other third party. Notwithstanding the foregoing, this release Agreement does not prohibit or bar Francese from providing truthful testimony in any legal proceeding or from cooperating with, or making truthful disclosures to, any governmental agency. Even though Francese intends to release all claims that he may have existing at the time of, or that Francese had prior to, the execution of this Agreement, this Agreement does not release Francese’s right to (i) any vested 401(k) or other retirement benefits to which he is or will be entitled, or (ii) any wages Francese has earned on or before the date he executes this Agreement. This release does not extend to any claims Francese has made or may make for workers’ compensation or unemployment compensation. Also, this Agreement does not release claims that cannot be released as a matter of law. For example, this Agreement does not release claims under the Fair Labor Standards Act of 1938. Francese’s release set forth in this Agreement does not release any subsequent breach of this Agreement. 10. From and after the Separation Date, Francese shall not represent himself as an employee, officer, director or representative of the Company or attempt to conduct business in the name or on behalf of the Company or any of its subsidiaries. Upon the Separation Date, Francese agrees to promptly return all items of Company property he has or over which he has control, including but not limited to all keys, records, lap top computer, cell phone, designs, business plans, financial statements, manuals, memoranda, lists, and other property delivered to or compiled by Francese by or on behalf of the Company (or its subsidiaries) or its representatives, vendors, or customers that pertain to the business of the Company (or its subsidiaries), all equipment belonging to the Company, all code and computer programs and information of whatever nature, tools, manuals, and any and all other materials, documents or information, including but not limited to confidential information in his possession or control, and that he will retain no copies thereof. Likewise, all correspondence, reports, records, charts, advertising materials, and other similar data pertaining to the business, activities or future plans of the Company (or its subsidiaries) that has been collected by Francese shall be delivered promptly to the Company upon the Separation Date. 11. Francese and the Company (together referred to as the “Parties”) mutually agree to maintain in strict confidence, and not to disclose, the terms, conditions, amount, fact of, and circumstances leading to the making of this Agreement, and any and all actions taken in accordance with this Agreement, provided however, that : (a) Francese may disclose this Agreement to his immediate family; (b) the Parties may disclose this Agreement in confidence to their respective attorneys, accountants, auditors, tax preparers, and financial advisors; (c) the Company may disclose this Agreement as necessary to Company employees for business-related reasons, or to others to fulfill standard or legally required corporate reporting or disclosure requirements; and (d) the Parties may disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law (including without limitation any disclosure requirement in connection with Francese’s application for unemployment insurance). Further, the Parties represent that they have not disclosed the fact of, or the terms of this Agreement and receipt of the payment described in Paragraph 3 to anyone, other than the permitted disclosures referenced above, at any time prior to execution of this Agreement. Francese specifically acknowledges and agrees that he shall not disclose the terms or existence of this Agreement to any current or former Company 6  employee in any manner, whether in writing or orally, directly or indirectly, or by or through an agent, representative, attorney or any other such person. In the event that any third party seeks to compel disclosure of this Agreement by service of a subpoena or otherwise, Francese agrees to promptly notify the Company and to limit any response to the specific information sought. 12. All notices, requests, consents and other communications hereunder that are required to be provided, or that the sender elects to provide, in writing, will be addressed to the receiving party’s address set forth below or to such other address as a party may designate by notice hereunder, and will be either (i) delivered by hand, (ii) sent by overnight courier, or (iii) sent by registered or certified mail, return receipt requested, postage prepaid. 13. Francese acknowledges, represents and warrants that he enters into this Agreement knowingly, voluntarily, free of duress or coercion, and with a full understanding of all terms and conditions contained herein. 14. Should any provision in this Agreement be declared or determined to be illegal or invalid the validity of the remaining parts, terms, or provisions shall not be affected and the illegal or invalid part, term, or provisions shall be deemed not to be part of this Agreement. 15. This Agreement and the agreements referenced herein, including the Restrictive Agreement, constitute the entire agreement between the parties, and supersede all oral negotiations and any prior and other writings with respect to the subject matter of this Agreement, and are intended by the parties as the final, complete and exclusive statement of the terms agreed to by them. 16. This Agreement shall be governed by and construed in accordance with the laws of the State of Rhode Island. 17. This Agreement shall be binding upon the parties and may not be amended, supplemented, changed, or modified in any manner, orally or otherwise, except by an instrument in writing of concurrent or subsequent date signed by the Company and Francese. 18. Francese agrees that he may not assign any of his rights or delegate any of his duties under this Agreement. The rights and obligations of the Company shall inure to the benefit of the Company’s successors and assigns. 7 If to the Company: If to Francese: Summer Infant (USA), Inc. Paul Francese Summer Infant, Inc. [Address] 1275 Park East Drive Woonsocket, Rhode Island 02895 Attn: Mark Strozik, SVP/ Human Resources  19. This Agreement shall not in any way be construed as an admission by the Company that it has acted wrongfully with respect to Francese and the specifically denies the commission of any wrongful acts against the other. 20. Francese agrees that he will not make any written or oral statement or take any action which he knows or reasonably should know constitutes an untrue, disparaging, or negative comment concerning the Company. Likewise, the Company agrees to instruct all current officers and current members of the Board of Directors not to make any written or oral statement or take any action which they know or reasonably should know constitutes an untrue, disparaging, or negative comment concerning Francese. 21. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together constitute one and the same instrument. [Remainder of Page Intentionally Left Blank] 8  IN WITNESS WHEREOF, the parties execute this Agreement as of the date indicated below. I have read this Agreement and understand that if I sign it I will be giving up important rights. I have been given ample opportunity to consult with and review this Agreement with an attorney of my choice. By signing below, I acknowledge that I willingly, voluntarily, and knowingly accept and agree to all the terms and conditions of this Agreement. 9 /s/ Paul Francese November 6, 2014 Paul Francese Date EMPLOYEE ID: Summer Infant (USA), Inc. and Summer Infant, Inc. /s/ Carol Bramson By: Carol Bramson Title: Chief Executive Officer Date: November 6, 2014 Attachments: Exhibit A: Non-Competition, Non-Disclosure and Developments Agreement dated July 10, 2013  Exhibit 10.19 Private and Confidential REVISED: October 6, 2014 William E. Mote, Jr [Address] Dear Bill: Further to recent discussions in respect of your employment with Summer Infant (USA), Inc. (“Summer”), Summer is pleased to offer you a full-time position as Chief Financial Officer (CFO) commencing on [TBD] . This offer is being extended in consideration of the mutual covenants and agreements contained in this letter (“Letter”), which sets forth our mutual understanding and agreement regarding your employment with Summer pursuant to the following terms and conditions. All offers of employment are conditional, subject to satisfactory results of background investigation, reference checks, pre-employment alcohol and drug tests, and production of documents sufficient to demonstrate identity and authorization to work. Position and Responsibilities: Your employment with Summer will commence on [TBD] . Your responsibilities will include, but are not limited to, CFO for Summer Infant, Inc. in our Corporate Office in Woonsocket Rhode Island and in such capacity, you will report directly to the CEO of Summer, Carol Bramson. The duties and services to be performed by you are collectively referred to herein as the “Services”. You agree that you shall at all times conscientiously perform all of the duties and obligations assigned to you to the best of your ability and experience and in compliance with law. You agree to use your best efforts to promote the interests of Summer and to devote your full business time and energies to the business and affairs of Summer and the performance of your Services. You represent and warrant to Summer that your execution of this Letter and the performance of your Services to Summer shall not violate any obligations you may have to any former employer, person or entity, including, without limitation, any restrictive obligations that would prevent you from the performance of your Services to Summer or any obligation with respect to proprietary or confidential information of any other person or entity.  Compensation : You will receive a bi-weekly ( every two weeks ) base salary of $10,961.54 ( annualized equivalent of $285,000 ), subject to applicable withholding and other lawful deductions. In addition to your base salary, you will be eligible to participate in Summer’s annual STI (Short-Term Incentive) bonus program with a target equal to 40% of your base salary compensation. This plan provides the opportunity to earn a bonus up to 80% of your base salary ( double your targeted bonus ) based on corporate and personal performance. You will also be eligible to participate in the company’s long-term incentive plan, and, subject to the approval of the Compensation Committee of the Board of Directors of Summer Infant, Inc. (“Parent”) you will be eligible for a hiring grant of 20,000 shares of restricted stock and 40,000 Stock Options ; such grant to be made in accordance with the company’s Incentive Compensation Plan. The equity will vest in 4 equal annual installments on our standard schedule of 25% per year, with the first 25% being fully vested on the first anniversary from date of hire. The specific mix and number of shares granted in future years as part of the annual equity grant program will be determined annually in line with the Company’s equity plan(s) and at the discretion of the Board of Directors. Performance Review and Benefits: You will be eligible for a performance and salary review in February 2016. You will also be eligible for Summer’s standard benefits subject to plan eligibility requirements. Summer’s current benefits include Medical benefits, Dental benefits, Vision Care, (available the first of the month following your date of hire), a 401K plan and match program (after 90 days) , Long-Term Disability (after 90 days), a Health Care Reimbursement Account , generous Product Discounts and 20 days of Paid Time Off per year, accrued at a rate of 6.15 hours bi-weekly (PTO includes vacation, sick and personal time ). Relocation: We have agreed that you will not be expected to relocate while your son is still in high school, that your standard work-week would encompass 5 days per week in the office, and that you will relocate within 3 months of your son’s graduation from high school. In the interim, we have also agreed that Summer will reimburse you for air travel expenses incurred in traveling between your home in Alabama and Summer’s headquarters for a period of up to 12 months. In addition, to assist you with lodging expenses, Summer will provide you with a gross amount of $30,000 (payable $2,500 per month for 12 months beginning with the month in which you are hired). In order to facilitate your transition, Summer will provide you with relocation support via reimbursement of up to $20,000 of relocation expenses upon presentation of appropriate receipts. In addition, Summer agrees to provide a “signing bonus” of $30,000 , payable on the first regular paydate following your move to a new residence within 60 miles of our corporate headquarters. In the unlikely event that you should choose to voluntarily terminate your employment with the Company within twelve (12) months of the end of your relocation window, you agree to reimburse Summer 100% of your total relocation expenses as described above (including relocation and signing bonus, but excluding lodging expenses).  Governing Law/At Will Employment: Your employment with Summer shall be governed by and interpreted in accordance with the laws of the State of Rhode Island. By execution and delivery of this Letter, you irrevocably submit to and accept the exclusive jurisdiction of the courts in the State of Rhode Island and waive any objection (including any objection to venue or any objection based upon the grounds of forum non conveniens) which might be asserted against the bringing of any such action, suit or other legal proceeding in such courts. While it is Summer’s desire to have a long-term employment relationship with you, your employment with Summer is “at will”, in that either you or Summer have the right to terminate the employment relationship at any time, with or without cause. This status may only be altered by written agreement, which is specific as to all material terms and is signed by an authorized officer of Summer. The terms of this employment letter do not, and are not, intended to create either an express and/or implied contract of employment with Summer for a definitive term. Notwithstanding the foregoing, in the event that your employment is terminated by Summer without cause or in the event that you terminate your employment with Summer for Good Reason (as hereinafter defined), then you shall be entitled to receive your base salary, then in effect, for a period of six (6) months following the termination of your employment payable in accordance with Summer’s customary payroll periods and practices and shall be less applicable taxes and withholdings (the “Severance Consideration”). You shall not be entitled to receive the Severance Consideration in the event that: (i) you voluntarily leave your employment for whatever the reason other than for Good Reason, (ii) your employment is terminated for Cause (as hereinafter defined), or (iii) as the result of your death or Disability (as hereinafter defined). You acknowledge and agree that Summer’s obligation to pay to you the Severance Consideration shall be conditioned upon you executing a General Release and Termination Agreement in favor of Summer. “ Cause ” means the occurrence of one or more of the following: (i) your willful and continued failure to substantially perform your Services for Summer, which failure continues for a period of at least thirty (30) days after written demand for substantial performance has been delivered by Summer to you which specifically identifies the manner in which you have failed to substantially perform your Services; (ii) your willful conduct which constitutes misconduct and is materially and demonstrably injurious to Summer, as determined in good faith by a vote of at least two-thirds of the non-Executive directors of the Board at a meeting of the Board at which you are provided an opportunity to be heard; (iii) your being convicted of, or pleading nolo contendere to a felony; or (iv) your being convicted of, or pleading nolo contendere to a misdemeanor based in dishonesty or fraud. “ Disability ” means that you have been unable to perform the Services as the result of your incapacity due to physical or mental illness, and such inability, at least four (4) weeks after its commencement, is determined to be total and permanent by a physical selected by Summer or its insurers and acceptable to you or your legal representative (such Agreement as to acceptability not to be unreasonably withheld). Termination resulting from Disability may only be affected after at least thirty (30) days’ written notice by Summer of its intention to terminate your employment. In the event that you resume the performance of substantially all of the Services hereunder before the  termination of your employment becomes effective, the notice of intent to terminate shall automatically be deemed to have been revoked. “ Good Reason ” means (i) the material diminution in your authority, duties or responsibilities; (ii) a material diminution in your annual base salary as in effect immediately prior to such diminution, other than in connection with a general diminution in Summer’s compensation levels and in amounts commensurate with the percentage diminutions of other Summer employees of comparable seniority and responsibility; or (iii) if applicable, any other action or inaction which constitutes a material breach by Summer of an agreement with you pursuant to which you provide services to Summer. No violation described in clauses (i) through (iii) above shall constitute Good Reason unless you have given written notice to Summer specifying the applicable clause and related facts giving rise to such violation within ninety (90) days after the occurrence of such violation and Summer has not remedied such violation to your reasonable satisfaction within thirty (30) days of its receipt of such notice. In addition, you will be entitled to protection against a change of control of Summer pursuant to the terms of a Change of Control Agreement in the form attached hereto as Exhibit 1 (the “CC Agreement”). The CC Agreement provides you, upon the occurrence of an event constituting a Change of Control, with certain Severance Benefits (as defined in the CC Agreement). In consideration of the Severance Benefits, you will be required to abide by the restrictive covenants contained in the CC Agreement. As a condition to your employment you will be required to execute and deliver the CC Agreement to Summer on the commencement date of your employment. Employment Documentation: Your employment with Summer is contingent upon your submission of satisfactory proof of your identity and legal authorization to work in the United States as well as completion of all employment related forms required by Summer. If you fail to provide satisfactory documentation, federal law prohibits Summer from hiring you. Expense Reimbursement: Summer will pay and/or reimburse you for all expenses reasonably and necessarily incurred by you in the performance of your services while employed by Summer, including reasonable and customary travel related expenses consistent with Summer’s corporate travel policy. Pursuant to Summer’s corporate travel policy, you may travel business class for air travel having a duration of 5 or more hours of flight time. Such payment/reimbursement shall be made upon presentation of such receipts or other documentation, as Summer customarily requires prior to making such payment or reimbursement.  Employment Manual : During your employment with Summer you will be required to abide by Summer’s code of conduct, policies, and procedures as set forth in Summer’s Employee Handbook or as otherwise communicated to you in writing. Restrictive Covenants: Please be advised that by accepting this offer of employment and in consideration of your employment with Summer, and the grant of restrictive stock in accordance with the terms hereof, you are agreeing to be bound by and adhere to the terms and conditions set forth in Appendix A, attached hereto and incorporated herein, which terms and conditions form a material condition to Summer in extending this letter to you. Return of Letter: We are excited about this opportunity to work with you to build the Summer Brand and Business. To accept this offer, please sign and date this Letter below ( as well as Appendix A and Exhibit 1 ), keep a copy for your records, and return a copy to Human Resources. We are extremely confident that your employment with us will prove mutually beneficial and we look forward to having you join our winning team! I accept your offer of employment as set forth in this letter and agree to be bound by the terms and conditions set forth in Appendix A, attached hereto. I understand that my employment is “at will” and that either you or I can terminate my employment at any time, for any reason. No oral commitments have been made concerning my employment. Very truly yours, Summer Infant USA, Inc. By: /s/ Mark Strozik Name: Mark Strozik Title: Senior Vice President / Human Resources William E. Mote, Jr. /s/ William E. Mote, Jr. Executive Name (please print) Executive Signature October 7, 2014 Date  QuickLinks -- Click here to rapidly navigate through this document Exhibit 23.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in Registration Statements (No. 333-156725 and 333-191405) on Form S-8 of Summer Infant, Inc. and Registration Statements (No. 333-164241 and 333-198315) on Form S-3 of Summer Infant Inc. of our report dated March 4, 2015, relating to our audits of the consolidated financial statements, included in this Annual Report on Form 10-K of Summer Infant, Inc. for the year ended January 3, 2015. /s/ McGladrey LLP McGladrey LLP Boston, MA March 4, 2015  QuickLinks Exhibit 23.1 Consent of Independent Registered Public Accounting Firm  QuickLinks -- Click here to rapidly navigate through this document Exhibit 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Carol E. Bramson, certify that: 1. I have reviewed this Annual Report on Form 10-K of Summer Infant, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. Date: March 4, 2015 /s/ CAROL E. BRAMSON Carol E. Bramson Chief Executive Officer  QuickLinks Exhibit 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER  QuickLinks -- Click here to rapidly navigate through this document Exhibit 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER I, William E. Mote, Jr. certify that: 1. I have reviewed this Annual Report on Form 10-K of Summer Infant, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.; 4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report)that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. Date: March 4, 2015 /s/ WILLIAM E. MOTE, JR. William E. Mote, Jr. Chief Financial Officer  QuickLinks Exhibit 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER  QuickLinks -- Click here to rapidly navigate through this document Exhibit 32.1 SECTION 1350 CERTIFICATION In connection with the Annual Report on Form 10-K of Summer Infant, Inc. (the "Company") for the year ended January 3, 2015 (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, I, Carol E. Bramson, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 4, 2015 /s/ CAROL E. BRAMSON Carol E. Bramson Chief Executive Officer  QuickLinks Exhibit 32.1 SECTION 1350 CERTIFICATION  QuickLinks -- Click here to rapidly navigate through this document Exhibit 32.2 SECTION 1350 CERTIFICATION In connection with the Annual Report on Form 10-K of Summer Infant, Inc. (the "Company") for the year ended January 3, 2015 (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, I, William E. Mote, Jr., Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 4, 2015 /s/ WILLIAM E. MOTE, JR. William E. Mote, Jr. Chief Financial Officer  QuickLinks Exhibit 32.2 SECTION 1350 CERTIFICATION 

Continue reading text version or see original annual report in PDF format above